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1. INTRODUCTION 
1.1 INTRODUCTION TO ANALYTICAL CHEMISTRY (P C Kamboj, 2003. 
Annees A. Siddiqui, 2006) 
   The pharmaceutical analysis defined as “the branch of practical chemistry 
which deals with the resolution, separation, identification, determination and 
purification of a given sample of a medicine, the detection and estimation of impurities, 
which may be present in drug substance (or) given sample of medicine”.  
The substance may be a single compound or a mixture of compounds and may 
be in the form a tablet, pill, capsule, ampoule, liquid, mixture or an ointment. 
The quality control tests involve methods which embrace chemicals,          
physio - chemical instrumental, microbiological (or) biological procedures. 
The pharmaceutical analysis deals with the subject of determining the 
composition of material in terms of the elements or compound (drug) present in the 
system. 
Any type of analysis involves two steps 
- Identification (qualitative) 
- Estimation (quantitative) 
In qualitative analysis, a reaction is performed in such a way as to indicate the 
formation of a precipitate, a change of a colour, the dissolution of a precipitate/ 
complex formation and the evaluation of a gas. 
Quantitative analysis is performed ordinarily through five steps. They are 
sampling, dissolution, precipitation, measurement and calculation. 
Method of assay 
It indicates the quantitative determination of principal ingredients of the official 
substances and in preparations. 
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Qualitative analysis 
This is practiced in order to establish the composition of a naturally occurring or 
artificially synthesized/ manufactured substance. 
Qualitative analysis 
I. Chemical Methods 
a) Titrimetric analysis 
b) Gravimetric analysis 
c) Gasometric analysis 
II. Physio - Chemical Methods (Instrumental Methods) 
III. Microbiological Procedures 
IV. Biological Procedures 
I.      Chemical Methods 
a. Titrimetric Analysis  
The analysis based on the fact that in all balanced chemical reactions utilized for 
the purpose. Equivalent weight of one substance reacts quantitatively with the 
equivalent weight of the other substance. The difference types of titration are as follows 
Acid base titrations (neutralization titrations) 
Non- aqueous titrations 
Redox titrations (redox = oxidation - reduction) 
Precipitation titrations 
Complexometric titrations 
b. Gravimetric Analysis 
This method involves the conversion of the element or a radical to be 
determined into a pure stable compound readily convertible into a form suitable for 
weighing. 
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c. Gasometric Analysis 
 This type of analysis involves the measurement of the volume of gases. The 
volume of a gas set free in a given chemical reaction under the conditions similar to 
those described in the process. It may be noted that the volume of gas is taken at normal 
conditions and pressure or standard temperature and pressure (NTP/ STP) which is a 
temperature of 00C (273.09o K) and the pressure of a column of 760mm/ Hg at 00C. If 
the reaction is taken place under different temperature and pressure, the volume is 
adjusted to standard conditions. A decrease in the volume of gas when a suitable 
reagent is placed to absorb one of the gases present. This decrease in volume is also 
reduced to STP. 
The gases cyclopropane, carbon di oxide, nitrogen oxide, oxygen, octyl nitrite, 
nitrogen, amyl nitrite, ethylene and helium are determined by gasometric analysis. The 
measurement of volume of gases is usually done by means of gas burettes or nitro 
meters. 
II. Physio - Chemical Methods (Instrumental Methods) 
Initially analytical methods were depending on extraction procedure, volumetric 
and gravimetric methods. All these methods are nearly replaced by advanced 
instrumental methods. These methods are more sensitive, specific and accurate but cost 
factors of the instruments and their maintenance are the main draw backs. Various 
instrumental methods are classified depending on the property analyzed. The following 
table shows different instrumental methods with basic principles. 
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S. N0. MEHTOD BASIC PRINCIPLE 
A ELECTROANALYTICAL METHODS 
1 Potentiometry 
Concerned with change in electrical properties of 
the system measures the change in electrode 
potential during a chemical reaction of the 
system 
2 Conductometry 
Measures the change in electrical conductivity 
during a chemical reaction 
3 Polarography 
Measure the current at various applied potential 
indicating the polarization at indicator electrode 
4 Amperometry 
Measure the change (or decrease) in current at a 
fixed potential during addition of titrant 
B SPECTROSCOPIC METHODS 
1 
Absorption 
Spectroscopy 
(Ultraviolet-Visible 
and Infrared) 
Measure the absorbance or percent transmittance 
during the interaction of monochromatic 
radiation (or particular wavelength) by the same 
2 Fluorimetry 
Measure the intensity of fluorescence caused by 
emission of electromagnetic radiation due to 
absorption of UV radiation 
3 Flame Photometry 
Measure the intensity of emitted light of 
particular wave length emitted by particular 
element 
4 Turbidimetry 
Measure the turbidity of a system by passing 
light beam in a turbid media 
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S. N0. MEHTOD BASIC PRINCIPLE 
5 Nephlometry 
Measure the opalescence of the medium by 
reflection of light by a colloidal solution 
6 
Atomic Absorption 
Spectrometry 
Measure the intensity of absorption when atoms 
absorbs the monochromatic radiation 
7 X-Ray Spectroscopy 
Measure the position and intensity of spectral 
lines during emission of X ray spectrum by 
atoms under influence of X rays 
8 Refractometry 
Measure the refractive index by causing 
refraction of light by matter 
9 Polarimetry 
Measure optical reaction by causing the rotation 
of plane polarized light 
10 Mass Spectroscopy 
Observe the position and intensity of signals in 
mass spectrum by causing the ionization of 
molecules 
11 NMR Spectroscopy 
Observe the position and intensity lines in NMR 
spectrum when proton interact with 
electromagnetic radiation in radio frequency 
region 
12 Thermal Methods 
Measure the physical parameters of the system 
as a function of temperature. It includes thermo 
gravimetry, derivative gravimetry, differential 
thermal analysis 
13 Radiometric Methods 
Measure the radioactivity either present 
naturally or induced artificially 
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III. Microbiological Methods 
In a microbiological assay, a comparison of inhibition of the growth of bacteria 
by a measured concentration of the antibiotic, which is to be examined, is made with 
that produced by known concentration of the standard preparation of an antibiotic 
having known activity. 
IV. Biological Methods 
When the potency of a drug or its derivative cannot be properly determined by 
physical or chemical methods and where it is possible to observe the biological effects 
of the drug on some type of living matter. The biological assays are carried out. The 
basis of such assay is to determine how much of the sample gives the same biological 
effect as a given quantity of the standard preparation. The sample and standard 
preparation are tested under identical conditions in all respect. In a typical bio – assay, a 
stimulus is applied to a subject is referred to as the dose and is indicated by a weight or 
in terms of the concentration of the preparation. The application of stimulus on a subject 
produces some observable effect and this is called the response. The response may be 
measured by the total weight or weight of some organ of the subject, blood sugar 
concentration, and diameter of inhibition zone or by some other physiological 
symptoms. 
1.2 ULTRAVIOLET SPECTROSCOPY    (Beckett and Stenlake, 2002)  
This technique of ultra violet spectroscopy is one of most frequently employed 
method in pharmaceutical analysis. It involves the measurement of the amount of UV 
radiation (190 - 380 nm) or visible (380 - 800 nm) radiation absorbed by a substance in 
solution. Ultraviolet spectroscopy involves the promotion of electrons (σ, π, n electrons) 
from the ground state to higher energy state. It is useful to measure the number of 
conjugated double bonds and also aromatic conjugation with the various molecules. 
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 The ultraviolet region of the electromagnetic spectrum is frequently 
subdivided into as follows: 
 Far vacuum Ultraviolet region (10 - 200 nm) 
 Near ultraviolet region (200 - 400 nm) 
 Visible region (380 - 780 nm) 
Origin and theory of ultraviolet spectra (Gurdeep R. Chatwal, et al., 2000) 
 Ultraviolet absorption spectra arise from transition of electron (or) electrons 
with in a molecule or anion from a lower to a higher electron energy level and the 
ultraviolet emission spectra arise from the reverse type of transmission. For radiation to 
cause electronic excitation it must be in the UV region of the electromagnetic spectrum. 
 Energy absorbed in the ultraviolet region produces change in the electronic 
energy of the molecule resulting from transition of valence electrons in the molecule. 
Three distinct types of electrons are involved in organic molecule. These are as follows 
σ – Electrons 
 Theses electrons are involved in saturated bonds, such as those between carbons 
and hydrogen in paraffins. These bonds are known as σ bonds. As the amount of energy 
required to excite electron in σ bonds is much more than that produced by UV light, 
compounds containing σ bonds do not absorb UV radiation. These electrons do not 
absorb near UV radiation but absorb at vacuum UV radiation.   
π – Electrons  
 These electrons are involved in unsaturated hydrocarbons. Typical compounds 
with π bonds are trienes and aromatic compounds. 
n– Electrons  
 These electrons are non bonded electrons which are not involved in any bonding 
between atoms in molecules. (eg.) S, O, N and halogens. 
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Types of Electronic Transitions (Y.R. Sharma, 2009) 
 A molecule is excited by the absorption of energy (UV or Visible light). Its 
electrons are promoted from a bonding to an anti bonding orbital. 
i. The anti bonding orbital which is associated with the excitation of σ – electrons 
is called σ* anti bonding orbital. It is represented as σ         σ* transition. 
ii. When a non - bonding electron gets promoted to an antibonding sigma orbital 
(σ*) then it represents n - σ* transition. 
iii. Similarly π        π* transition represents the promotion of π electrons to an anti 
bonding π* orbital. 
iv. When n - electron (non - bonding) is promoted to anti bonding π orbital. It 
represents n        π* transition. 
v.                                    
 
         Electronic excitation energies 
1.2.1 Visible Spectrophotometry (Mendham et al. 2002, B.K. Sharma, 2006) 
 Visible spectrophotometry involves the measurement of the amount of visible 
radiation (400 - 800 nm) absorbed by a colour solution. Using this, the quality of an 
element present is estimated from the intensity of the colour of the solution due to the 
presence of a coloured compound of that element. The more intense colour is the higher 
concentration of the element in solution. 
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 Some compounds are self coloured and for other it is necessary to develop 
colour by the addition of one or more colour forming reagents (chromogenic reagents). 
The absorbing capacity of a coloured system is directly proportional to the amount of 
desired constituent. 
Colorimetric analysis should satisfy following criteria. 
• The colour reaction should be specific 
• Proportionality change between colour and concentration 
• Colour should be stable to permit an accurate reading  
• Reproducible result should be notified 
• Solution must be free from precipitate 
• The colour reaction should be highly sensitive 
In physics colorimetry refers to the measurement of colour and the 
determination involves neither the nature of the colourant nor its amounts. In chemistry, 
a general term called absorptiometry is used for chemical analysis through measurement 
of radiation. 
 Chemical systems which exhibit a selective light absorptive capacity or 
coloured, and hence the terms colorimetric analysis and colorimetry are often applied to 
the measurements of such system when the object is to determine the concentration of 
the consistutents responsible for the colour. In other words the variation of some 
component forms the basis of colorimetric analysis and it is concerned with the 
determination of the concentration of a substance by measurement of the relative 
absorption of light with respective of a known concentration of substance. 
Colorimetric analysis is of two types: 
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Visual Colorimetry  
This is the type of analysis in which natural or artificial white light is used as a 
light source and determinations are usually made with a colorimetry or colour 
comparator. 
Photo Electric Colorimetry  
In this type of analysis, eye is replaced by photo electric cell. The latter 
eliminates the error due to the personal characteristics of the observer. Photo electric 
colorimetry is usually employed with light contained within a comparatively narrow 
range of wavelengths obtained by passing white light through filters. The most 
important advantage of the colorimetric and spectrophotometric analysis is that they 
provide a significant method of determining minute quantities of substances. Some 
compounds are self coloured and other compounds are not. It is usually necessary to 
develop a colour by the addition of one or more colour forming agents. Chemical 
methods used to prepare suitable coloured solutions are usually called chromogenic 
reactions. The colour forming reagents are known as chromogenic reagents. The 
preparation of the coloured substance is as important as the measurement step in the 
visible spectrometry and hence in order to get good results a careful attention is 
extremely important while preparing a coloured solution. 
The absorption capacity of a coloured system is directly proportional to the 
amount of the desired constituent; however the effect of other substance present in 
sample must known and the optimum condition under which the chromogenic reagent 
reacts with desired constituent. 
The following are the most important prosperities of a coloured system which 
are suitable for measurement. 
 
11 
 
Sensitivity 
The solution should be intensely coloured. Hence an easily detectable change in 
intensity must be obtained by small changes in the concentration. In this manner very 
small amount of the constituents can be determined. 
Specificity 
Only the desired constituent or some definitely related to it should develop a 
colour. 
Stability 
In order to make reliable measurement the intensity of the coloured solution 
should remain constant for long period. 
Reproducibility 
The hue as well as the intensity of the coloured solution must reproducible. The 
effect of the order of addition of reagents, the pH and other solution variables should be 
directly delineated. 
Conformity to Beer’s law 
The measurement may be facilitated both for single and poly component system 
if Beers law is obeyed by the coloured solution. If Beers law does not confirm, adequate 
precautions are necessary. 
The absorption laws (Y.R. Sharma, 2009) 
 There are two laws which govern the absorption of light by the molecules. 
These are, 
(1) Lambert’s Law 
(2) Beer’s Law 
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Lambert’s Law 
 When a beam of monochromatic radiation passes through a homogenous 
absorbing medium, the rate of decrease of intensity of radiation with thickness of 
absorbing medium is proportional to the intensity of incident radiation. 
I = I0e-kt 
Where,  I0 = Intensity of incident light 
  I = Intensity of emerged light 
  t = Thickness of the medium 
Beer’s Law 
When a beam of monochromatic radiation is passed through a solution of an 
absorbing substance, the rate of decrease of intensity of radiation with concentration of 
the absorbing solution is directly proportional to the intensity of incident radiation.  
I = I0e-kc 
Where,  I0 = intensity of incident light 
 I = Intensity of emerged light 
 c = concentration of the absorbing species 
From these laws, the following empirical expression of Beer - Lambert’s Law was 
constructed 
Log (I0/IT) = Єct =A 
Where,  A= Absorbance or optical density or extinction 
 Є = Molar extinction co-efficient 
  c = Concentration of drug  
  t = Path length 
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Limitations of Beer Lambert’s Law  
1. When different forms of the absorbing molecules are in equilibrium as in keto-
enol tautomers. 
2. When fluorescence compounds are present. 
3. When solute and solvent forms complex through some sorts of association. 
Deviations from Beer’s Law  (Gurdeep R. Chatwal, et al., 2000) 
 According to Beer’s law, a straight line passing through the origin should be 
obtained, when a graph is plotted between absorbance and concentration. But there is 
always a deviation from linear relationship between absorbance and concentration and 
intact the shape of an absorption curve usually changes with changes in concentration of 
solution and unless precautions are observed. Deviations from the law may be positive 
or negative according to whether the resulting curve is concave upward or concave 
downward.                              
 
The latter two are generally known as instrumental deviation and chemical deviation. 
Instrumental deviations 
 Stray radiation, improper slit width, fluctuation in single beam. 
Chemical deviations 
 Hydrolysis, Association, Polymerization, Ionization, Hydrogen bonding. 
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Deviations from Beer’s Law can arise due to the following factors 
1. Beer’s law will hold over a wide range of concentration provided the 
structure of coloured ion or of the coloured non electrolyte in the dissolved 
state does not change with concentration. If a coloured solution is having a 
foreign substance whose ions do not react chemically with the coloured 
components, its small concentration does not affect the light absorption and 
may also alter the value of extinction co - efficient. 
2. Deviations may also occur if the coloured solute ions dissociates or 
associates. 
3. Deviations may also occur due to the presence of impurities that 
fluorescence or absorb at absorption wavelength. 
4. Deviations may occur if monochromatic light is not used. 
5. Deviations may occur if the width of slit is not proper and therefore it 
allows undesirable radiations to fall on the detector. 
6. Deviations may occur if the solution undergoes polymerization. 
7. Beer’s law cannot apply to suspensions but the latter can estimated 
calorimetrically after preparing a reference curve with known 
concentrations. 
Choice of solvent (Gurdeep R. Chatwal, et al., 2000) 
 A suitable solvent for ultraviolet spectroscopy should meet the following 
requirements. 
(i) It should not itself absorb radiations in the region under investigation. 
(ii) It should be less polar so that it has minimum interaction with the solute molecule. 
The most commonly employed solvent is 95% ethanol. It is cheap, has good 
dissolving power and does not absorb radiation above 210 nm. In other words it is 
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transparent above 210 nm. Commercial ethanol should not be used as it contains some 
benzene which undergoes absorption in the UV range at about 280. Some other solvents 
which are transparent above 210 nm are n-hexane, cyclohexane, methanol, water and 
ether, benzene, chloroform, and carbon tetrachloride cannot be used because they 
absorb in the range of about 240 - 280 nm. 
Hexane and other hydrocarbon are sometimes preferred to polar solvents 
because they have minimum interaction with the solute molecules. 
Solvent Effects 
 The position and the intensity of absorption maximum is shifted for a particular 
chromophore by changing the polarity of the solvent. By increasing the polarity of 
solvent, compounds like dienes and conjugated hydrocarbons do not experience any 
appreciable shift. The absorption maximum for the polar compounds is usually shifted 
with the change in polarity of the solvents. α and β unsaturated carbonyl compounds 
show two different shifts. 
a) n       π* transition  
The absorption band moves to short wavelength by increasing the polarity of the 
solvent. In n        π* transition the ground state is more polar as compared to the excited 
state. The hydrogen bonding with solvent molecules take place to lesser extent with the 
carbonyl group in the excited state. 
b) π        π* transition 
The absorption band moves to longer wavelength by increasing the polarity of the 
solvent. The dipole interactions with the solvent molecules lower the energy of the 
excited state more than that of the ground state. 
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Chromophores and Auxochromes (Jagmohan, 2005) 
A. Chromophores 
“The presence of one or more unsaturated groups responsible for electronic 
absorption is called as chromophores”. 
e.g. C = C, C ≡ C, C = N, C ≡ N, C = O 
B. Auxochromes 
An auxochrome is an auxiliary group which interacts with the chromophore causing 
a bathochromic shift. The presence of auxochrome causes a shift in the UV or Visible 
absorption maximum to the longer wavelength. 
e.g. NH2, NR2, OH, OR, SH, NHR.  
1.2.1.1 Instrumentation (Gurdeep R. Chatwal, et al., 2000) 
All photometers, colorimeters and spectrophotometers have the following basic 
components 
i) Radiation Source  
For UV region 
Hydrogen discharge lamp, Deuterium discharge lamp, Xenon arc Lamp. 
For Visible region 
 The tungsten halogen lamp is the most common source of visible radiation. 
ii) Filters and Monochromatoros 
 The filters and monochromators are used to disperse the radiation according to 
the wavelength. The essential of a monochromator are an entrance slit, a dispersing 
element and an exit slit. The entrance slit sharply defines the incoming beam of 
heterochromatic radiation. The dispersing element disperses the heterochromatic 
radiation into its component wavelengths where as exit slit allows the nominal 
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wavelength together with a band of wavelength on either side of it. The position of the 
dispersing element is always adjusted by rotating it to vary the nominal wavelength 
passing through the exit slit.  
For UV region  
The dispersing element may be a prism or grating. The prisms are generally 
made of glass, quartz or fused silica. Glass has the highest resolving power but it is not 
transparent to radiation having the wavelength between 2000 and 3000 A because glass 
absorbs strongly in this region. Quartz and fused silica prism which are transparent 
throughout the entire UV range are widely used in UV spectrophotometers.  
Types of monochromators 
 1) Prisms 
 2) Gratings  
1) Prisms are of two types 
  i) Refractive prism 
 ii) Reflective prism 
2) Gratings are of two types 
 i) Diffraction grating 
 ii) Transmission grating 
For Visible region 
 Filters or monochromators or both are used  
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Filters  
 A light filter is a device that allows light of the required wavelength to pass but 
absorbs light of other wavelengths wholly or partially. Thus, a suitable filter can be 
select a desired wavelength band. It means that a particular filter may be used for a 
specific analysis. If analysis is carried out for several species, a large number of filters 
have to be used and interchanged. This method is very useful for routine analysis. 
Types of filters 
 Filters are two types, 
 i) Absorption filters 
ii) Interference filters 
iii) Sample cell 
These are containers for the sample and reference solutions and must be 
transparent to the radiation passing through. 
UV region  
The cells made up of quartz. 
Visible region  
The cells made of glass. 
iv) Detectors 
Detectors used in UV/Visible spectrophotometers can be called as photometric 
detectors. In these detectors the light energy is converted to electrical signal which can 
be recorded. The types of detectors used are   
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Barrier Layer cell (or) Photo Voltaic cell. 
Photo tubes (or) Photo emissive tubes 
Photomultiplier tubes  
Photo diode 
1.2.2 Difference Spectrophotometry (Beckett and Stenlake, 2002) 
 The selectivity, accuracy of spectrophotometric analysis of samples containing 
absorbing interferents may be markedly improved by the technique of difference 
spectrophotometric assay is that the measured value is the difference absorbance (A) 
between two equimolar solutions of the analyte in different chemical forms which 
exhibits difference spectral characteristics. The criteria for applying difference 
spectrophotometry to the assay of a substance in the presence of other absorbing 
substances are that 
 Reproducible changes may be induced in the spectrum of analyte by the 
addition of one or more reagents. 
 The absorbance of the interfering substance is not altered by the 
reagents. 
The simplest and most commonly employed technique for altering the spectral 
properties of the analyte is the adjustment of the pH by means of aqueous solutions of 
acid, alkali or buffers. The ultra violet visible absorption spectra of many substances 
containing ionisable functional groups, e.g. phenols, aromatic carboxylic acids and 
amines, are dependent on the state of ionization of the functional groups and 
consequerently on the pH of the solution. 
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The measured value in a quantitative difference spectrophotometric assay is the 
∆A at any suitable wavelength measured to the baseline, e.g. ∆A1 at λ1 or amplitude 
between an adjacent maximum and minimum, e.g:  ∆A2 at λ2 and λ1 
∆A = Aalk –Aacid 
 
Where, Aalk and Aacid are the individual absorbances at λ1 in 0.1M sodium 
hydroxide and 0.1M hydrochloric acid solution, respectively. 
∆A = ∆ abc 
1.2.3 Quantitative Spectrophtometric Methods (Beckett and Stenlake, 2002) 
 The assay of an absorbing substance may be quickly carried out by preparing a 
solution in a transparent solvent and measuring its absorbance at a suitable wavelength. 
The wavelength normally selected is a wavelength of maximum absorption (λmax), 
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where small errors in setting the wavelength scale have little effects on the measured 
absorbance. 
a. Assay of substances in single component samples 
 Absorption spectroscopy is one of the most useful tools available to the chemist 
for quantitative analysis. The most important characteristics of photometer and 
spectrophotometric method are high selectivity and ease of convenience. Quantitative 
analysis (assay of an absorbing substance) can be done using following methods. 
-    Use of A	% 	 values 
-    Use of calibration graph (multiple standard method) 
-     By single or double point standardization method. 
i)  Use of 		
% 	 values 
 This method can be used for estimation of drug from formulations or raw 
material, when reference standard not available. The use of standard value A	%  avoids 
the need to prepare a standard solution of the reference substance in order to determine 
its absorptivity, and is of advantage in situations where it is difficult or expensive to 
obtain a sample of the reference substance. 
ii. Use of calibration graph 
 In this procedure the absorbances of a number (typically 4-6) of standard 
solutions of the reference substance at concentrations encompassing the sample 
concentrations are measured and a calibration graph is constructed. The concentration 
of the analyte in the sample solution is read from the graph as the concentration 
corresponding to the absorbance of the solution. Calibration data are essential if the 
absorbance has a non-linear relationship with concentration, or if the absorbance or 
linearity is dependent on the assay conditions. In certain visible spectrophotometric 
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assays of colorless substances, based upon conversion to coloured derivatives by 
heating the substance with one or more reagents, slight variation of assay conditions, 
e.g. PH, temperature and time of heating, may rise to a significant variation of 
absorbance, and experimentally derived calibration data are required for each set of 
samples. 
iii. Single or double point standardization 
          The single point procedure involves the measurement of the absorbance of a 
sample solution and of a standard solution of the reference substance. The standard and 
the sample solution are prepared in similar manner; ideally the concentration of the 
standard solution should be close to that of the sample solution. The concentration of 
the substance in the sample is calculated using following formula. 
                                    Ctest = Atest × Cstd / Astd 
Where,
 
 
Ctest and Cstd are the concentration in the sample and standard solutions 
respectively.  
Atest and Astd are the absorbance of the sample and standard solutions 
respectively. 
 In double point standardization, the concentration of one of the standard solution 
is greater than that of the sample while the other standard solution has a lower 
concentration than the sample. The concentration of the substance in the sample 
solution is given by  
                                           (Atest – Astd1)(Cstd1-Cstd2) +Cstd1 (Astd1-Astd2) 
                            Ctest =                    
                                                                     Astd1-Astd2 
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Where, 
Cstd is the concentration of the standard solution.  
Atest and Astd are the absorbance of the sample and standard solution 
respectively. 
Std1 and Std2 are the more concentrated standard and less concentrated standard 
respectively. 
1.3 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
(Sethi, P.D., 1996, Sethi, P.D., Dilip Chareganokar.1999) 
HPTLC is a most versatile and simple technique for both qualitative and 
quantitative analysis of drugs in the pure state, to those extracted from pharmaceutical 
formulations and to biological samples. This technique is the advancement of the thin 
layer chromatography. It involves the same principle of thin layer chromatography but 
differs from thin layer chromatography in parameters such as speed, accuracy and cost 
of analysis. Unlike other chromatographic techniques, HPTLC does not require more 
space or bulk instrument or any special training for the handling of instruments. 
1.3.1 Steps Involved 
The various steps involved in the process of HPTLC are selection of plates, 
sample preparation, pre-washing of plates, activation of plates, application of the 
sample, development and detection. 
1.3.1.1 Selection of plates 
The plates used in HPTLC are either handmade plates or pre-coated plates. The 
handmade plates differ from the pre-coated plates in the support material. The thickness 
of the plates varies from 100 to 250 µm. The sorbent used in the plates are cellulose, 
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cellulose with starch, microcrystalline cellulose, silica gel, silica gel G, silica gel with 
starch and acetylated cellulose 
The handmade plates are made with a glass support whereas; the pre-coated 
plates are made with supports such as polyester sheets and aluminum sheets. 
1.3.1.2 Pre-washing 
The pre-washing is done to remove any impurity that might have adhered to the 
plate surface. The adsorbents coated over the plate have the tendency to absorb the 
atmospheric moisture and other impurities suspended in the air. Thus pre-washing 
prevents any interference of the impurity during the development of the chromatogram. 
The pre-washing is done by ascending, dipping or by continuous mode. 
Methanol is the commonly used solvent for the washing of plates. The solvents such as 
methanol in chloroform (1:1), ethyl acetate in methanol (1:1), chloroform: methanol: 
ammonia (90:10:1) are also used in the pre-washing of the plates 
1.3.1.3 Activation of plates 
The plates are activated by placing it in a oven at 110 to 120º C for 30 minutes. 
Activation removes any moisture which maybe physically absorbed to the surface of the 
plate. 
1.3.1.4 Application of sample 
The application of sample is done using a device. The improper application may 
lead to improper resolution of the samples. While applying the sample, care must be 
taken so that the layer of the adsorbent is not damaged. The sample spots are made as 
bands for better separation. 
1.3.1.5 Mobile phase 
The solvents used in the preparation of mobile phase must be of good quality as 
poor grade of solvents decreases the resolution of the sample. The components of the 
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mobile phase are measured separately and then are mixed in a vessel and then 
introduced into the developing chamber. The mobile phase should not react with the 
analyte or the stationary phase used. 
1.3.1.6 Chamber saturation 
Chamber saturation is done by allowing the mobile phase to completely saturate 
inside the closed chamber only with mobile phase. The chamber saturation helps in 
faster development of the chromatogram. Unsaturated chamber gives improper Rf 
values due to the evaporation of the solvents at the solvent front. 
1.3.1.7 Development and detection 
After the chamber saturation the plates are developed using any one of the 
various methods available. The development techniques are ascending, descending, two 
dimensional, horizontal, radial etc. The tanks or the chambers used in the development 
process are twin trough chambers, rectangular chambers, circular chambers and 
automated multiple development chambers. 
After the development the plates are removed and dried to evaporate the mobile 
phase. The detection is made by using UV, visible light and by fluorescence. 
Derivatizations are required for those samples which do not respond to UV light 
or does not have fluorescence. Densitometry is in situ measurement of visible light,   
UV radiations and fluorescence on the plate. 
1.3.2 Factors Influencing HPTLC 
The resolution and separation of spots in a HPTLC system are influenced by 
various parameters such as type of stationary phase, thickness of adsorbent, mobile 
phase, developing chamber, size of the sample spot, mode of development and relative 
humidity. 
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1.4 ANALYTICAL METHOD VALIDATION 
(Code Q2A; Q2B; ICH Guidelines, U.S.P) 
1.4.1 Introduction 
This document presents a discussion of the characteristics for consideration 
during the validation of the analytical procedures included as part of registration 
applications submitted within the EC, Japan and USA.  This document does not 
necessarily seek to cover the testing that may be required for registration in, or export 
to, other areas of the world. Furthermore, this text presentation serves as a collection 
of terms, and their definitions, and is not intended to provide direction on how to 
accomplish validation.  These terms and definitions are meant to bridge the 
differences that often exist between various compendia and regulators of the EC, 
Japan and USA. 
The objective of validation of an analytical procedure is to demonstrate that it 
is suitable for its intended purpose.  A tabular summation of the characteristics 
applicable to identification, control of impurities and assay procedures is included.  
Other analytical procedures may be considered in future additions to this document. 
Types of Analytical Procedures to be Validated 
The discussion of the validation of analytical procedures is directed to the four 
most common types of analytical procedures. They are identification tests, 
quantitative tests for impurities content, limit tests for the control of impurities and 
quantitative tests of the active moiety in samples of drug substance or drug product or 
other selected component(s) in the drug product. 
Although there are many other analytical procedures, such as dissolution 
testing for drug products or particle size determination for drug substance, these have 
not been addressed in the initial text on validation of analytical procedures. Validation 
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of these additional analytical procedures are equally important to those listed herein 
and may be addressed in subsequent documents. 
A brief description of the types of tests considered in this document is 
provided below. 
 - Identification tests are intended to ensure the identity of an analyte in a 
sample.  This is normally achieved by comparison of a property of the sample      
(e.g., spectrum, chromatographic behaviour, chemical reactivity, etc) to that of a 
reference standard. 
 - Testing for impurities can be either a quantitative test or a limit test for the 
impurity in a sample. Either test is intended to accurately reflect the purity 
characteristics of the sample. Different validation characteristics are required for a 
quantitative test than for a limit test. 
 - Assay procedures are intended to measure the analyte present in a given 
sample. In the context of this document, the assay represents a quantitative 
measurement of the major component(s) in the drug substance.  For the drug product, 
similar validation characteristics also apply when assaying for the active or other 
selected component(s). The same validation characteristics may also apply to assays 
associated with other analytical procedures (e.g., dissolution). 
The objective of the analytical procedure should be clearly understood since this 
will govern the validation characteristics which need to be evaluated. Typical 
validation characteristics which should be considered are listed below 
Accuracy 
Precision  
Repeatability 
Intermediate Precision 
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Specificity 
Detection Limit 
Quantitation Limit 
Linearity 
Range 
Each of these validation characteristics is defined in the attached Glossary. The 
table lists those validation characteristics regarded as the most important for the 
validation of different types of analytical procedures.  This list should be considered 
typical for the analytical procedures cited but occasional exceptions should be dealt 
with on a case-by-case basis.  It should be noted that robustness is not listed in the 
table but should be considered at an appropriate stage in the development of the 
analytical procedure. 
Furthermore revalidation may be necessary in the following circumstances 
  - Changes in the synthesis of the drug substance 
  - Changes in the composition of the finished product 
  - Changes in the analytical procedure. 
The degree of revalidation required depends on the nature of the changes. Certain 
other changes may require validation as well. 
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EVALUATION SIGNIFICANCE TABLE 
Type of analytical 
procedures 
IDENTIFICATION TESTING FOR 
IMPURITIES 
ASSAY 
- dissolution 
(measurement only) 
- content/potency 
characteristics  Quantitation    limit  
Accuracy -          +               - + 
Precision  
Repeatability 
Intermediate Precision 
 
- 
- 
 
         +                - 
         + (1)  - 
 
+ 
      + (1) 
Specificity (2) +          +   + + 
Detection Limit -           - (3) + - 
Quantitation Limit -          +               - - 
Linearity -          +    - + 
Range -          +               - + 
- signifies that this characteristic is not normally evaluated 
+ signifies that this characteristic is normally evaluated 
(1) In cases where reproducibility (see glossary) has been performed, intermediate 
precision is not needed 
(2)  Lack of specificity of one analytical procedure could be compensated by other 
supporting analytical procedure(s) 
(3) May be needed in some cases 
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 1.4.2 GLOSSARY 
ANALYTICAL PROCEDURE 
The analytical procedure refers to the way of performing the analysis. It should 
describe in detail the steps necessary to perform each analytical test. This may include 
but is not limited to: the sample, the reference standard and the reagents preparations, 
use of the apparatus, generation of the calibration curve, use of the formulae for the 
calculation, etc. 
 SPECIFICITY 
Specificity is the ability to assess unequivocally the analyte in the presence 
of components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. Lack of specificity of an individual analytical 
procedure may be compensated by other supporting analytical procedure(s). 
This definition has the following implications: 
Identification: to ensure the identity of an analyte. 
Purity Tests: to ensure that all the analytical procedures performed allow an accurate 
statement of the content of impurities of an analyte, i.e. related substances test, 
heavy metals, residual solvents content, etc. 
Assay (content or potency):  
 To provide an exact result this allows an accurate statement on the content or 
potency of the analyte in a sample. 
ACCURACY 
The accuracy of an analytical procedure expresses the closeness of 
agreement between the value which is accepted either as a conventional true value or 
an accepted reference value and the value found. This is sometimes termed trueness. 
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 PRECISION  
The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple sampling 
of the same homogeneous sample under the prescribed conditions. Precision may be 
considered at three levels:  repeatability, intermediate precision and reproducibility. 
Precision should be investigated using homogeneous, authentic samples. 
However, if it is not possible to obtain a homogeneous sample it may be investigated 
using artificially prepared samples or a sample solution. 
The precision of an analytical procedure is usually expressed as the variance, 
standard deviation or coefficient of variation of a series of measurements. 
REPEATABILITY 
Repeatability expresses the precision under the same operating conditions over a 
short interval of time. Repeatability is also termed intra-assay precision. 
INTERMEDIATE PRECISION 
Intermediate precision expresses within-laboratories variations: different days, 
different analysts, different equipment, etc. 
REPRODUCIBILITY 
Reproducibility expresses the precision between laboratories (collaborative 
studies, usually applied to standardization of methodology). 
DETECTION LIMIT  
The detection limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be detected but not necessarily quantitated as an exact 
value. 
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QUANTITATION LIMIT 
The quantitation limit of an individual analytical procedure is the lowest 
amount of analyte in a sample which can be quantitatively determined with suitable 
precision and accuracy. The quantitation limit is a parameter of quantitative assays for 
low levels of compounds in sample matrices, and is used particularly for the 
determination of impurities and/or degradation products. 
LINEARITY 
The linearity of an analytical procedure is its ability (within a given range) to 
obtain test results which are directly proportional to the concentration (amount) of 
analyte in the sample. 
RANGE 
The range of an analytical procedure is the interval between the upper and lower 
concentration (amounts) of analyte in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. 
ROBUSTNESS 
The robustness of an analytical procedure is a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage. 
 
 
 
33 
 
1.4.3 VALIDATION OF ANALYTICAL PROCEDURES 
METHODOLOGY 
INTRODUCTION 
This document is complementary to the parent document which presents a 
discussion of the characteristics that should be considered during the validation of 
analytical procedures. Its purpose is to provide some guidance and recommendations on 
how to consider the various validation characteristics for each analytical procedure. In 
some cases (for example, demonstration of specificity), the overall capabilities of a 
number of analytical procedures in combination may be investigated in order to ensure 
the quality of the drug substance or drug product. In addition, the document provides an 
indication of the data which should be presented in a registration application. 
All relevant data collected during validation and formulae used for calculating 
validation characteristics should be submitted and discussed as appropriate. 
Approaches other than those set forth in this guideline may be applicable and 
acceptable. It is the responsibility of the applicant to choose the validation procedure 
and protocol most suitable for their product. However it is important to remember that 
the main objective of validation of an analytical procedure is to demonstrate that the 
procedure is suitable for its intended purpose. Due to their complex nature, analytical 
procedures for biological and biotechnological products in some cases may be 
approached differently than in this document. 
Well-characterized reference materials, with documented purity, should be used 
throughout the validation study. The degree of purity necessary depends on the intended 
use. 
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In accordance with the parent document, and for the sake of clarity, this 
document considers the various validation characteristics in distinct sections. The 
arrangement of these sections reflects the process by which an analytical procedure may 
be developed and evaluated. 
In practice, it is usually possible to design the experimental work such that the 
appropriate validation characteristics can be considered simultaneously to provide a 
sound, overall knowledge of the capabilities of the analytical procedure, for instance: 
specificity, linearity, range, accuracy and precision. 
SPECIFICITY 
An investigation of specificity should be conducted during the validation of 
identification tests, the determination of impurities and the assay. The procedures used 
to demonstrate specificity will depend on the intended objective of the analytical 
procedure.  
It is not always possible to demonstrate that an analytical procedure is specific 
for a particular analyte (complete discrimination). In this case a combination of two or 
more analytical procedures is recommended to achieve the necessary level of 
discrimination. 
Identification  
Suitable identification tests should be able to discriminate between compounds 
of closely related structures which are likely to be present. The discrimination of a 
procedure may be confirmed by obtaining positive results (perhaps by comparison with 
a known reference material) from samples containing the analyte, coupled with negative 
results from samples which do not contain the analyte. In addition, the identification test 
may be applied to materials structurally similar to or closely related to the analyte to 
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confirm that a positive response is not obtained. The choice of such potentially 
interfering materials should be based on sound scientific judgement with a 
consideration of the interferences that could occur.  
Assay and Impurity Test (s)  
For chromatographic procedures, representative chromatograms should be used 
to demonstrate specificity and individual components should be appropriately labelled. 
Similar considerations should be given to other separation techniques.  
Critical separations in chromatography should be investigated at an appropriate 
level. For critical separations, specificity can be demonstrated by the resolution of the 
two components which elute closest to each other. 
In cases where a non-specific assay is used, other supporting analytical 
procedures should be used to demonstrate overall specificity. For example, where a 
titration is adopted to assay the drug substance for release, the combination of the assay 
and a suitable test for impurities can be used. The approach is similar for both assay and 
impurity tests 
Impurities are available 
For the assay, this should involve demonstration of the discrimination of the 
analyte in the presence of impurities and/or excipients; practically, this can be done by 
spiking pure substances (drug substance or drug product) with appropriate levels of 
impurities and/or excipients and demonstrating that the assay result is unaffected by the 
presence of these materials (by comparison with the assay result obtained on unspiked 
samples). 
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For the impurity test, the discrimination may be established by spiking drug 
substance or drug product with appropriate levels of impurities and demonstrating the 
separation of these impurities individually and/or from other components in the sample 
matrix. 
Impurities are not available 
If impurity or degradation product standards are unavailable, specificity may be 
demonstrated by comparing the test results of samples containing impurities or 
degradation products to a second well-characterized procedure e.g. pharmacopoeial 
method or other validated analytical procedure (independent procedure). As 
appropriate, this should include samples stored under relevant stress conditions: light, 
heat, humidity, acid/base hydrolysis and oxidation.  
- For the assay, the two results should be compared; 
- For the impurity tests, the impurity profiles should be compared. 
Peak purity tests may be useful to show that the analyte chromatographic peak is 
not attributable to more than one component (e.g., diode array, mass spectrometry). 
LINEARITY 
A linear relationship should be evaluated across the range (see section 3) of the 
analytical procedure. It may be demonstrated directly on the drug substance (by dilution 
of a standard stock solution) and/or separate weighing of synthetic mixtures of the drug 
product components, using the proposed procedure. The latter aspect can be studied 
during investigation of the range. 
Linearity should be evaluated by visual inspection of a plot of signals as a 
function of analyte concentration or content. If there is a linear relationship, test results 
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should be evaluated by appropriate statistical methods, for example, by calculation of a 
regression line by the method of least squares. In some cases, to obtain linearity 
between assays and sample concentrations, the test data may need to be subjected to a 
mathematical transformation prior to the regression analysis. Data from the regression 
line itself may be helpful to provide mathematical estimates of the degree of linearity.  
The correlation coefficient, y-intercept, slope of the regression line and 
residual sum of squares should be submitted. A plot of the data should be included. In 
addition, an analysis of the deviation of the actual data points from the regression line 
may also be helpful for evaluating linearity. 
Some analytical procedures, such as immunoassays, do not demonstrate 
linearity after any transformation. In this case, the analytical response should be 
described by an appropriate function of the concentration (amount) of an analyte in a 
sample.  
For the establishment of linearity, a minimum of 5 concentrations is 
recommended. Other approaches should be justified. 
RANGE  
The specified range is normally derived from linearity studies and depends on 
the intended application of the procedure. It is established by confirming that the 
analytical procedure provides an acceptable degree of linearity, accuracy and precision 
when applied to samples containing amounts of analyte within or at the extremes of the 
specified range of the analytical procedure. The following minimum specified ranges 
should be considered: 
- for the assay of a drug substance or a finished (drug) product: normally from 80 to 
120 percent of the test concentration;  
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- for content uniformity, covering a minimum of 70 to 130 percent of the test 
concentration, unless a wider more appropriate range, based on the nature of the dosage 
form (e.g., metered dose inhalers), is justified; 
- For dissolution testing: +/-20 % over the specified range;  
e.g., if the specifications for a controlled released product cover a region from 20%, 
after 1 hour, up to 90%, after 24 hours, the validated range would be 0-110% of the 
label claim.  
- For the determination of an impurity: from the reporting level of an impurity to 
120% of the specification; for impurities known to be unusually potent or to produce 
toxic or unexpected pharmacological effects, the detection/quantitation limit should be 
commensurate with the level at which the impurities must be controlled; 
Note: for validation of impurity test procedures carried out during development, it may 
be necessary to consider the range around a suggested (probable) limit. 
- if assay and purity are performed together as one test and only a 100% standard is 
used, linearity should cover the range from the reporting level of the impurities to 120% 
of the assay specification. 
ACCURACY 
Accuracy should be established across the specified range of the analytical 
procedure.  
Assay 
Drug Substance 
Several methods of determining accuracy are available 
 a)  Application of an analytical procedure to an analyte of known purity        
(e.g. reference material) 
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b)  Comparison of the results of the proposed analytical procedure with those of 
a second well-characterized procedure, the accuracy of which is stated and/or defined 
(independent procedure, see 1.2.) 
 c)  Accuracy may be inferred once precision, linearity and specificity have been 
established. 
Drug Product 
Several methods for determining accuracy are available 
 a)  Application of the analytical procedure to synthetic mixtures of the drug 
product components to which known quantities of the drug substance to be analysed 
have been added 
 b)  in cases where it is impossible to obtain samples of all drug product 
components , it may be acceptable either to add known quantities of the analyte to the 
drug product or to compare the results obtained from a second, well characterized 
procedure, the accuracy of which is stated and/or defined (independent procedure,      
see 1.2.) 
 c)  Accuracy may be inferred once precision, linearity and specificity have been 
established. 
Impurities (Quantitation) 
Accuracy should be assessed on samples (drug substance/drug product) spiked 
with known amounts of impurities. 
In cases where it is impossible to obtain samples of certain impurities and/or 
degradation products, it is considered acceptable to compare results obtained by an 
independent procedure (see 1.2.). The response factor of the drug substance can be 
used. 
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It should be clear how the individual or total impurities are to be determined 
e.g., weight/weight or area percent, in all cases with respect to the major analyte. 
Recommended Data 
Accuracy should be assessed using a minimum of 9 determinations over a 
minimum of 3 concentration levels covering the specified range (e.g., 3 concentrations/ 
3 replicates each of the total analytical procedure). 
Accuracy should be reported as percent recovery by the assay of known added 
amount of analyte in the sample or as the difference between the mean and the accepted 
true value together with the confidence intervals. 
PRECISION 
Validation of tests for assay and for quantitative determination of impurities 
includes an investigation of precision. 
Repeatability 
Repeatability should be assessed using 
 a)  a minimum of 9 determinations covering the specified range for the 
procedure (e.g., 3 concentrations/3 replicates each) 
 b)     a minimum of 6 determinations at 100% of the test concentration. 
Intermediate Precision 
The extent to which intermediate precision should be established depends on the 
circumstances under which the procedure is intended to be used. The applicant should 
establish the effects of random events on the precision of the analytical procedure. 
Typical variations to be studied include days, analysts, equipment, etc. It is not 
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considered necessary to study these effects individually. The use of an experimental 
design (matrix) is encouraged. 
Reproducibility 
Reproducibility is assessed by means of an inter-laboratory trial. Reproducibility 
should be considered in case of the standardization of an analytical procedure, for 
instance, for inclusion of procedures in pharmacopoeias. These data are not part of the 
marketing authorization dossier.  
Recommended Data 
The standard deviation, relative standard deviation (coefficient of variation) and 
confidence interval should be reported for each type of precision investigated. 
DETECTION LIMIT 
Several approaches for determining the detection limit are possible, depending 
on whether the procedure is a non-instrumental or instrumental. Approaches other than 
those listed below may be acceptable. 
Based on Visual Evaluation 
Visual evaluation may be used for non-instrumental methods but may also be 
used with instrumental methods. 
The detection limit is determined by the analysis of samples with known 
concentrations of analyte and by establishing the minimum level at which the analyte 
can be reliably detected. 
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Based on Signal-to-Noise  
This approach can only be applied to analytical procedures which exhibit 
baseline noise. Determination of the signal-to-noise ratio is performed by comparing 
measured signals from samples with known low concentrations of analyte with those of 
blank samples and establishing the minimum concentration at which the analyte can be 
reliably detected. A signal-to-noise ratio between 3 or 2:1 is generally considered 
acceptable for estimating the detection limit. 
Based on the Standard Deviation of the Response and the Slope 
The detection limit (DL) may be expressed as 
DL =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
     S = the slope of the calibration curve 
The slope S may be estimated from the calibration curve of the analyte. The 
estimate of σ may be carried out in a variety of ways, for example 
Based on the Standard Deviation of the Blank 
 Measurement of the magnitude of analytical background response is performed 
by analyzing an appropriate number of blank samples and calculating the standard 
deviation of these responses.  
Based on the Calibration Curve 
A specific calibration curve should be studied using samples containing an 
analyte in the range of DL. The residual standard deviation of a regression line or the 
standard deviation of y-intercepts of regression lines may be used as the standard 
deviation.  
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Recommended Data 
The detection limit and the method used for determining the detection limit 
should be presented. If DL is determined based on visual evaluation or based on 
signal to noise ratio, the presentation of the relevant chromatograms is considered 
acceptable for justification. 
In cases where an estimated value for the detection limit is obtained by 
calculation or extrapolation, this estimate may subsequently be validated by the 
independent analysis of a suitable number of samples known to be near or prepared at 
the detection limit.  
QUANTITATION LIMIT 
Several approaches for determining the quantitation limit are possible, 
depending on whether the procedure is a non-instrumental or instrumental. 
Approaches other than those listed below may be acceptable. 
Based on Visual Evaluation 
Visual evaluation may be used for non-instrumental methods but may also be 
used with instrumental methods. 
The quantitation limit is generally determined by the analysis of samples with 
known concentrations of analyte and by establishing the minimum level at which the 
analyte can be quantified with acceptable accuracy and precision.  
Based on Signal-to-Noise  
This approach can only be applied to analytical procedures that exhibit 
baseline noise. 
Determination of the signal-to-noise ratio is performed by comparing 
measured signals from samples with known low concentrations of analyte with those 
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of blank samples and by establishing the minimum concentration at which the analyte 
can be reliably quantified. A typical signal-to-noise ratio is 10:1.  
Based on the Standard Deviation of the Response and the Slope 
The quantitation limit (QL) may be expressed as: 
QL = 
     10 σ 
         S 
Where,      σ = the standard deviation of the response 
     S = the slope of the calibration curve 
The slope S may be estimated from the calibration curve of the analyte. The 
estimate of σ may be carried out in a variety of ways for example:  
Based on Standard Deviation of the Blank 
Measurement of the magnitude of analytical background response is 
performed by analyzing an appropriate number of blank samples and calculating the 
standard deviation of these responses.  
Based on the Calibration Curve 
A specific calibration curve should be studied using samples, containing an 
analyte in the range of QL. The residual standard deviation of a regression line or the 
standard deviation of y-intercepts of regression lines may be used as the standard 
deviation.  
Recommended Data 
The quantitation limit and the method used for determining the quantitation 
limit should be presented. 
The limit should be subsequently validated by the analysis of a suitable 
number of samples known to be near or prepared at the quantitation limit.  
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ROBUSTNESS 
The evaluation of robustness should be considered during the development 
phase and depends on the type of procedure under study. It should show the reliability 
of an analysis with respect to deliberate variations in method parameters. 
If measurements are susceptible to variations in analytical conditions, the 
analytical conditions should be suitably controlled or a precautionary statement 
should be included in the procedure. One consequence of the evaluation of robustness 
should be that a series of system suitability parameters (e.g., resolution test) is 
established to ensure that the validity of the analytical procedure is maintained 
whenever used. 
Examples of typical variations are 
- Stability of analytical solutions; 
- Extraction time. 
In the case of liquid chromatography, examples of typical variations are 
- Influence of variations of pH in a mobile phase, 
- Influence of variations in mobile phase composition, 
- Different columns (different lots and/or suppliers), 
- Temperature, 
- Flow rate. 
In the case of gas-chromatography, examples of typical variations are 
- Different columns (different lots and/or suppliers) 
- Temperature 
- Flow rate. 
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1.5 STATICAL PARAMETERS (Mendham et al. 2002) 
Linear Regression 
 Once linear relationship has been shown to have a high probability by the 
value of the correlation coefficient ‘r’ then the best straight line through the data 
points has to be estimated. This can be often done by visual inspection of graph but in 
many cases it is far more sensible   to evaluate the best straight line by linear 
regression.  
The equation of straight line is  
Y = mx + c 
Where, y the dependent variable is plotted as result changing x the independent 
variable. 
 To obtain regression line ‘y ‘ on ‘x ‘ the slope ‘m’ of the line intercept ‘c’ on 
the y axis are given by the following formula. 
            
m = N∑xy	 −	(∑ x)	(∑ y)N∑ x −	(∑ x)  
 
c	 = (∑y)	(∑x
)	–	(∑ x)	(∑ xy)
N∑x −	(∑ x)  
  
Correlation Coefficient  
The correlation co-efficient is used as a measure of the correlation between two 
variables. When variables x and y are correlated rather than being functionally related. 
The person correlation co efficient is one of the most convenient to calculate. This is 
given by 
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r = n	∑ xy −	∑ xyn	 ∑ x −	(∑ x	n	 ∑ y −	(∑ y 
 
 
Where n is the number of data points.  
The maximum, value of r is 1. When this occurs, there is exact correlation 
between the two variables. When r is zero, there is complete independence of the 
variables. The minimum value of r is -1. A negative correlation co-efficient indicates 
that the assumed dependence is opposite to what exists and therefore a positive co-
efficient for the revered relation. The fit must be quite poor before r become smaller 
than about 0.98 and is really very poor when less than 0.9. 
Residual Sum of Square 
 This is a measure of the variability of the data around the line of best fit that 
has been defined by linear regression. If all the data fall exactly on the calculated line 
of best fit, this would imply that the experiment has no associated error and, 
accordingly, the Residual Sum of Squares is equal to zero, the Residual Sum of 
Squares is calculated with knowledge of the total and regression sum of squares as 
follows. 
 SSresidual     =  SStotal – SSregression   
Where,  
 SStotal          =   ∑(y – Y)2 =  ∑y2	–	∑X
	– 	(∑X)    
 SSregression =  (	∑Xy)	–	(	∑X	∑y/n)

∑x	–	(∑X)/n"  
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Standard Deviation 
 It is commonly used in statistics as a measure of precision and is more 
meaning full than is the average deviation. It may be thought of as a root mean square 
deviation of values from their average and is expressed mathematically as 
    
Where  
S = Standard deviation 
If N is large (50 or more) then of course it of immaterial whether the term in the 
denomination is N - 1 or N. 
Σ         = sum 
x        = Mean or arithmetic average. 
x -x 
 
 = Deviation of a value from the mean 
N       = Number of observations 
Percentage Relative Standard Deviation (% RSD) 
 It is also known as co efficient of variation CV. It is defined as the standard 
deviation (SD) expressed as the percentage of mean. 
                        RSD (%)    = 100
x
S.D
×  
Where,  
SD = Standard deviation 
  The variance is defined as S2 and is more important in statistics than S itself. 
However the latter is much more commonly used with chemical data. 
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Standard Error of Mean (SE) 
  The standard error of mean can be defined as the value obtained by the 
division of standard deviation by square root of number of observations. It is 
mathematically expressed as,  
SE. = 
n
S.D
 
Where, 
SD = Standard deviation. 
N = number of observations. 
Confidence Interval (CI) 
 When a small number of observations are made, the value of the standard 
deviation S does not by itself give a measure of how close the sample mean #̅ might 
be to the true mean. But it is possible to calculate a Confidence Interval to estimate 
the range with in which the true mean may be found. The limits of this Confidence 
Interval known as the Confidence Limits. 
 
%& = 	 #̅ − '∝
	,*+
,
√ , #̅ + '∝	,*+
,
√  
Where, 
 T = Parameters that depends up on the number of degrees of freedom x 
 S = Average Standard Deviation 
 #̅ = Average mean 
 n = Number of observations 
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2. LITERATURE REVIEW 
2.1 DRUG PROFILE 
(http://www.drugs.com/monograph/tapentadol-hydrochloride.html) 
(http://www.chemspider.com/Chemical-Structure.8013742.html#pred) 
(http://www.medlink.com/medlinkcontent.asp) 
(http://www.druglib.com/druginfo/nucynta/indications_dosage/) 
(http://www.rxlist.com/nucynta-drug.htm) 
(Certificate of Analysis from MSN Organics Pvt. Ltd) 
2.1.1 Tapentadol Hydrochloride 
Molecular structure 
 
Chemical name 
3-[(1R, 2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride 
Molecular formula C14H23NO.HCl 
Molecular weight 257.8 
Category Centrally acting opioid analgesic.  
Description White to off white crystalline powder 
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Solubility Tapentadol Hdrochloride is highly soluble in methanol, water and 
insoluble in n-heptane. 
Identification test 
i) Melting point 
Standard value Observed value* 
194-196˚C 194.33˚C 
   *Mean of six observations 
іі) IR spectrum was recorded and shown in figure 1. 
Storage Preserve in well-closed containers at controlled room temperature. 
pKa value 9.34 and 10.45 
Mechanism of action 
Tapentadol Hydrochloride have dual mode of action as an agonist at the        
µ-opioid receptor and as a nor-epinephrine reuptake inhibitor, there is potential for off 
label use in chronic pain. 
Side effects 
Nausea, dizziness, constipation, and CNS sedation are common side effects of 
opioid pain medications. Tapentadol Hydrochloride may cause hallucinations and 
short term memory loss to patients on anti-depressants. 
Pharmacological action 
Pharmacodynamics 
Tapentadol is a centrally acting oral analgesic with a dual mechanism of action, 
combining µ-opioid receptor agonist and norepinephrine reuptake inhibition in a 
single molecule. Norepinephrine plays a role in the endogenous descending pain 
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inhibitory system, and the analgesic efficacy of norepinephrine reuptake inhibitors has 
been shown in neuropathic pain. 
Analgesic effect of Tapentadol has been demonstrated in a wide range of animal 
models of pain with nociceptive and neuropathic components, and development of 
tolerance to its analgesic effect was twice as slow as that of morphine. Although 
Tapentadol has a 50-fold lower binding affinity to µ - opioid receptor, its analgesic 
potency is only 2 to 3 times lower than that of morphine, indicating that the dual 
mode of action may result in an opiate-sparing effect (Tzschentke et al 2007). 
Pharmacokinetics 
 A study investigated the absorption, metabolism, and excretion of tapentadol in 
humans using oral 3-[14C]-labeled Tapentadol Hydrochloride (Terlinden et al 2007). 
Important findings were 
- Drug absorption was rapid, reaching a maximum concentration of 2.45 microg-
eq/mL in 1.25 to 1.5 hours. 
-  The drug was present mainly in the form of conjugated metabolites. 
-  Excretion was renal and complete within 5 days. 
The absolute oral bioavailability of Tapentadol is approximately 32%, which is 
comparable to that of morphine (Tzschentke et al 2006). 
2.2 REPORTED METHODS 
2.2.1 Analytical Methods 
2.2.1.1 James A. Bourland et al., (2010), reported “Determination of Tapentadol 
and N-Desmethyltapentadol in Authentic Urine Specimens by Ultra-
Performance Liquid Chromatography-Tandem Mass Spectrometry” An Acquity 
UPLC was coupled with a tandem quadrupole detector (TQD) operating in positive 
ESI mode for analysis (Waters, Milford, MA). The UPLC column was a Waters 
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Acquity UPLC® BEH Shield RP18 (2.1 mm × 50 mm × 1.7 µm). The column 
manager temperature was held at 50°C, and the injection volume was 5 µL. The 
mobile phase was made up of 0.1% formic acid (Solvent A) and acetonitrile (Solvent 
B). The mobile phase composition initially was 90% A/10% B with a flow rate of   
0.4 mL/min and during the cycle increased up to 90% acetonitrile by 1.50 min, 
returning to the original composition at 2.0 min, with a total cycle time between 
injections of 3.0 min. The source temperature was set to 150°C and desolvation 
temperature at 450°C. The desolvation gas was nitrogen and the collision gas was 
argon with flow rates of 500 L/h and 0.18 mL/min, respectively.  
2.2.1.2 Cynthia Coulter et al., (2010), reported “Determination of Tapentadol and 
its Metabolite N-Desmethyltapentadol in Urine and Oral Fluid Using Liquid 
Chromatography with Tandem Mass Spectral Detection” A 1200 series LC pump 
coupled to a 6410 triple-quadrupole MS, operating in positive electrospray ionization 
mode (ESI) mode was used for analysis (Agilent Technologies, Santa Clara, CA). The 
LC column (Agilent Technologies) was a Zorbax Eclipse XDB C18                        
(4.6 × 50 mm × 1.8 mm). The column temperature was held at 40°C. The injection 
volume for oral fluid was 5 µl; the injection volume for urine was 2 µl. The mobile 
phase consisted of 20 mm ammonium formate (pH 6.4) (Solvent A) and methanol 
(Solvent B). Initially, the mobile phase composition was 85% A:15% B at a flow rate 
of 0.7 ml/min. Over 4 min, the percentage of methanol was increased to 100%. The 
gas temperature was 350°C, the gas flow was 10 L/min, and the nebulizer pressure 
was 50 psi. Nitrogen was used as the collision gas, and the capillary voltage was  
4000 V. 
2.2.1.3 Ravikumar K et al., (2011), reported “Four Stereoisomers of the Novel        
µ-Opioid Receptor Agonist Tapentadol Hydrochloride” The crystal and molecular 
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structures of four stereoisomers of Tapentadol Hydrochloride [systematic name:          
3-(3-hydroxyphenyl)-N,N,2-trimethylpentan-1-aminium chloride], C14H24NO+·Cl-, a 
novel analgesic agent, have been determined by X-ray crystal structure analysis. 
Resolution of the isomers was carried out by reverse-phase and chiral high-
performance liquid chromatographic (HPLC) methods. Stereoisomers (I) and (II) 
crystallize in the monoclinic space group P21, each with two Tapentadol cations and 
two chloride anions in the asymmetric unit, while stereoisomers (III) and (IV) 
crystallize in the orthorhombic space group P212121, with one tapentadol cation and 
one chloride anion in the asymmetric unit. The absolute configurations of the four 
enantiomers were determined unambiguously by X-ray crystallography. The crystal 
structures reveal the stereochemistries at the 3-ethyl and 2-methyl groups to be R,R, 
S,S, S,R and R,S in stereoisomers (I)-(IV), respectively. The ethyl and aminopropyl 
groups adopt different orientations with respect to the phenol ring for (I) and (IV). In 
all four structures, the chloride ions take part in N-H----Cl and O-H----Cl hydrogen 
bonds with the tapentadol molecules, resulting in one-dimensional helical chains in 
the crystal packing in each case. 
2.2.2 Clinical Methods 
2.2.2.1 Schroder W et al., reported (2011), “Synergistic Interaction Between the 
Two Mechanisms of Action of Tapentadol in Analgesia” This study was designed 
to investigate the nature of the interaction of the two mechanisms (µ-opioid receptor 
(MOR) agonism and noradrenaline reuptake inhibition (NRI)). Pharmacological 
antagonism studies have demonstrated that both mechanisms of action contribute to 
the analgesic effects of Tapentadol. Dose-response curves were generated in rats for 
Tapentadol alone or in combination with the opioid antagonist naloxone or the       
α(2)-adrenoceptor antagonist yohimbine. Two different pain models were used:        
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1) low-intensity tail-flick and 2) spinal nerve ligation. Tapentadol produced dose-
dependent analgesic effects in both pain models, and its dose-effect curves were 
shifted to the right by both antagonists, thereby providing data to distinguish between 
MOR agonism and NRI This may explain why Tapentadol is only 2- to 3-fold less 
potent than morphine across a variety of preclinical pain models despite its 50-fold 
lower affinity for the MOR. This is probably the first demonstration of a synergistic 
interaction between the occupied receptors for a single compound with two 
mechanisms of action. 
2.2.2.2 Smit JW et al., (2010), reported “Effect of Acetaminophen, Naproxen and 
Acetylsalicylic acid on Tapentadol Pharmacokinetics: Results of Two 
Randomized, Open-Label, Crossover, Drug-Drug Interaction Studies”. In both 
randomized and crossover studies, Tapentadol immediate release (IR) 80 mg were 
administered as a single oral dose alone. In the 2-way crossover study, Tapentadol IR 
was also given with the fifth of seven doses of acetaminophen 1000 mg; in the 3-way 
crossover study, Tapentadol IR was also given with the third of four doses of 
naproxen 500 mg and the second of two doses of acetylsalicylic acid 325 mg. All 
treatments were separated by a washout period of 7-14 days. No clinically relevant 
changes were noted in the serum concentrations of Tapentadol, and accordingly, no 
dosage adjustments with respect to the investigated pharmacokinetic mechanism of 
interaction are warranted for the administration of Tapentadol given concomitantly 
with acetaminophen, naproxen, or acetylsalicylic acid. 
2.2.2.3 Rolf Terlinden et al., (2007), reported “Absorption, Metabolism, and 
Excretion of 14C-Labeled Tapentadol Hydrochloride in Healthy Male Subjects”. 
Four healthy male subjects received a single 100-mg oral dose of 3-[14C]-labeled 
Tapentadol Hydrochloride for evaluation of the pharmacokinetics of the drug and the 
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excretion balance of radiocarbon. The concentration-time profiles of radiocarbon in 
whole blood and serum and radiocarbon excretion in the urine and feces, and the 
expired carbon di oxide were determined. Absorption was rapid (with a mean 
maximum serum concentration [Cmax], 2.45 µg-eq/m]; a time to Cmax, 1.25–1.5 h), and 
the drug was present primarily in the form of conjugated metabolites 
(conjugated:unconjugated metabolites = 24∶1). Excretion of radiocarbon was rapid 
and complete (>95% within 24 h; 99.9% within 5 days) and almost exclusively renal 
(99%∶69% conjugates; 27% other metabolites; 3% in unchanged form). It was found 
that a single oral dose of Tapentadol was rapidly absorbed, then excreted into the 
urine, primarily in the form of conjugated metabolites, and was well tolerated. 
2.2.2.4 Xu et al., (2010), reported “Population Pharmacokinetics of Tapentadol 
Immediate Release (IR) in Healthy Subjects and Patients with Moderate or 
Severe Pain” The analysis included pooled data from 11 385 serum pharmacokinetic 
samples from 1827 healthy subjects and patients with moderate to severe pain. The 
population pharmacokinetic model for Tapentadol IR identified the relationship 
between pharmacokinetic parameters and a wide range of covariates. The simulations 
of Tapentadol exposure with identified, statistically significant covariates 
demonstrated that only hepatic function (as characterized by total bilirubin and total 
protein) may be considered a clinically relevant factor that warrants dose adjustment. 
None of the other covariates are of clinical relevance, nor do they necessitate dose 
adjustment. 
2.2.2.5 William E et al., (2010), reported “Tapentadol Hydrochloride: A Centrally 
Acting Oral Analgesic” The purpose of this article is to review animal studies, 
pharmacokinetic studies, drug-drug interaction studies, and Phase II/III trials of 
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Tapentadol in various conditions producing moderate to severe pain. Tapentadol 
appears to be a well-tolerated and effective analgesic for the treatment of moderate to 
severe acute pain. Although not currently approved for the management of chronic 
pain, Tapentadol has been reported to be effective in managing pain associated with 
osteoarthritis and low back pain. 
2.2.2.6 Kwong WJ et al., (2010), reported “Cost-Effective Analysis of Tapentadol 
Immediate Release for the Treatment of Acute Pain” this analysis compared the 
cost – effectiveness of Tapentadol IR with doses of Oxycodone IR providing 
comparable analgesia in the outpatient treatment of acute postsurgical and nonsurgical 
pain. A markov model was developed to simulate clinical-economical outcomes for 
Tapentadol IR 100 mg compared with Oxycodone IR 15 mg in the treatment of acute 
postsurgical pain (3 days) and for Tapentadol IR 50 mg compared with Oxycodone IR 
10 mg in the treatment of acute nonsurgical pain (10 days). The results of this model 
suggest that at doses providing comparable analgesia, Tapentadol IR is cost-effective 
alternative to Oxycodone IR for the treatment of acute surgical and nonsurgicl pain. 
2.2.2.7 Raritan NJ et al(2008), reported “FDA Approves Tapentadol Immediate 
Release Tablets for Relief of Moderate to Severe Acute Pain”. Johnson & Johnson 
Pharrmaceutical research & development, L.L.C., announced that the U.S. food and 
drug administration approved Tapentadol immediate-release tablets for the relief of 
moderate to severe acute pain in adults 18 years of age or older. Tapentadol is a new 
centrally acting oral analgesic. It has two mechanisms of action, combining µ-opioid 
receptor agonism and norepinephrine reuptake inhibition. Tapentadol tablets have 
been approved in 50 mg, 75 mg, and 100 mg doses. 
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3. AIM AND PLAN OF WORK 
3.1 AIM OF WORK  
The drug analysis plays an important role in the development, manufacture and 
therapeutic use of drug. Most of the pharmaceutical industries do the quantitative 
chemical analysis  to ensure that the raw material used and the final product thus 
obtained meet certain specifications  and to determine how much of each components 
are present in the final product. 
Standard analytical procedure for newer drugs or formulation may not be 
available in pharmacopoeias hence it is essential to develop newer analytical methods 
which are precise, accurate, specific, linear, simple and rapid. UV and HPLC grades of 
solvents used for respective determination and solvent should readily available and 
cheaper. The solvent should be completely extracting the active ingredient from 
formulation. 
 Tapentadol Hydrochloride is an opioid analgesic. Its main use is to treat the 
moderate to severe acute pain, and first approved in the USA for this purpose. This is a 
newer drug available in Indian market and CDSCO approves this on April 2011. 
Extensive literature survey revealed that the determination of Tapentadol and  
N-desmethyltapentadol in authentic urine specimens by UPLC - Tandem Mass 
Spectrometry has been reported. However there is no evidence for the estimation of 
Tapentadol Hydrochloride by   UV - Visible spectrophotometry and HPTLC in bulk and 
in tablet formulation. 
Hence the present work, aims to develop a simple, precise and accurate methods 
for the estimation of Tapentadol Hydrochloride in bulk and in pharmaceutical dosage 
form by using UV spectroscopy, visible spectrophotometry and HPTLC and to validate 
the developed methods. 
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3.2 PLAN OF WORK 
3.2.1 Survey on Literature 
The survey on literature performed for Tapentadol Hydrochloride for their 
physiochemical properties, solubility, pharmacology and analytical techniques. So this 
basic information gives notation for newer method development. 
3.2.2 Method Development 
1) Identification of drug by its melting point and IR spectral studies. 
2) Selection of suitable solvent for quantitative extraction of drug present in the 
formulations. The solvent should be readily available, economical and of 
analytical grade for UV-spectroscopy, visible spectrophotometry and HPTLC. 
The solvent should not interact with the compound of interest and its structural 
characteristics. 
3) Selection of method for analysis, depending on the spectral characteristics of 
the drug. 
4) Selection of suitable wavelength for rapid and accurate simple UV and 
Difference spectrophotometric methods development.  
5) Development of simple, cost effective and accurate visible spectrophotometric 
methods. 
6) Development of simple and accurate HPTLC method. 
7) Analysis of marketed formulations. 
8) Validation of developed analytical methods. 
9) Statistical analysis of developed analytical methods. 
3.2.3 Validation of Developed Method 
The developed method should be validated as per ICH guidelines. The 
parameters used to validate the developed method are Specificity, Linearity, Range, 
Accuracy, Precision, Limit of Detection, Limit of Quantification, Robustness and 
Ruggedness.
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4. MATERIALS AND METHODS 
4.1 MATERIALS 
4.1.1 Drug Samples (Raw material) 
               Tapentadol Hydrochloride was obtained as a gift sample from MSN 
Laboratories Limited, Hyderabad. 
4.1.2 Formulation Used 
              Tapol-100 tablets containing Tapentadol Hydrochloride 100 mg was procured 
from MSN Laboratories Limited, Hyderabad.                   
4.1.3 Chemicals and Solvents Used 
           Distilled water, Sodium hydroxide (AR Grade), MBTH reagent (AR Grade), 
Hydrochloric acid (AR Grade), Ceric Ammonium Sulphate (AR Grade), Sulphuric acid 
(AR Grade), Potassium Ferricyanide (AR Grade), Ferric Chloride(AR Grade), 
Methanol (AR Grade), Ethyl Acetate (AR Grade), Hexane (AR Grade) were purchased 
from Qualigens India Pvt. Limited, Mumbai and Loba Chemie India Limited, Mumbai. 
4.1.4 Instruments Used 
 Different instruments used to carry out the present work are 
1) Shimadzu AUX - 220 Digital balance 
2) Shimadzu - 1700 Double Beam UV - Visible spectrophotometer with pair of   
10 mm matched quartz cells 
3) ELICO SL - 210 Double Beam UV - Visible spectrophotometer with pair of      
10 mm matched quartz cells 
4) HPTLC Instrument (Camag) 
5) ELICO pH meter (Model LI - 120) 
6) SOLTEC – Sonica ultrasonic cleaner – Model 2200 MH 
7) REMI – Centrifuge apparatus 
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8) CYBERLAB – Micropipette 
9) SUNBIM – Melting point apparatus          
4.1.5 Specifications (Terms) of instruments 
4.1.5.1 Shimadzu AUX - 220 Digital Balance (Shimadzu Instruction Manual) 
 
                                              Specifications 
     Weighing capacity 200 gms 
     Minimum display 0.1 mg 
     Standard deviation ≤ 0.1 mg 
     Operation temperature range 5 to 40° C 
 
4.1.5.2 Double Beam UV - Visible Spectrophotometer (Shimadzu and ELICO 
Instruction Manuals) 
 Model: Shimadzu UV - 1700; Double beam UV - Visible spectrophotometer. 
              ELICO SL – 210; Double beam UV - Visible spectrophotometer. 
Specification Shimadzu UV - 1700 Elico SL – 210 
Light source 20 W halogen lamp, 
Deuterium lamp,  
Light source position 
automatic adjustment 
mechanism. Built in lamp 
lighting time display 
function. 
Tungsten halogen lamp (W), 
Deuterium lamp (D), 
 Light source position 
automatic adjustment 
mechanism. 
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Monochromator  Aberration- correcting 
concave blazed holographic 
grating 
Concave holographic grating 
with 1200 lines/ mm 
Detector Silicon photodiode Photodiode 
Stray Light 0.04% or less (220 nm; 
NAI 10g/ lt) 
0.04% or less (340 nm; 
NaNo2 50g/ lt). 
< 0.05% T at 220 nm with 
NAI  10g/ lt 
Measurement  
Wavelength range 
190 ~ 1100 nm 190 ~1100 nm 
Spectral Band width 1 nm or less                   
(190 to 900nm). 
1.8 nm
Wave length Accuracy ± 0.5 nm on broad 
automatic wavelength 
calibration mechanism. 
± 0.5 nm automatic 
wavelength calibration 
mechanism. 
Recording range Absorbance;                           
- 3.99 ~ 3.99 Abs 
Transmittance;                                             
- 399 ~ 399% 
Absorbance; ± 3.000 Abs 
 
Photometric accuracy ± 0.004 Abs (at 1.0 Abs). 
± 0.002 Abs (at 0.5 Abs). 
± 0.005 Abs (at 1.0 Abs). 
± 0.010 Abs (at 0.5 Abs). 
Operating  
Temperature/ 
Temperature range; 15 to 
35˚C 
Temperature range; 15 to 
35˚C 
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Humidity 
 
Humidity range; 
35 to 80% (15 to below 
35˚C) 
35 to 70% (30 to below 
35˚C) 
Humidity range; 
35 to 80% (15 to below 
35˚C) 
35 to 70% (30 to below 
35˚C) 
 
 
4.1.5.3 HPTLC instrument – Camag 
Specifications 
Sample Applicator Linomat IV with Camag100µl Syringe 
Chamber Camag Twin trough Glass Chamber 
(20x10) 
Scanner Camag TLC Scanner III 
Software Wincat software 
Development temp Ambient 
Stationary Phase HPTLC plates(Merck) precoated with 
silicagel 60 F254 on aluminium sheets 
Development time 20 min 
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4.2 METHODS 
 In the present work an attempt was made to develop and validate simple, 
precise and accurate methods for the estimation of Tapentadol Hydrochloride in pure 
form and in tablet dosage form. The methods developed were the following 
1) UV spectroscopy  
2) Difference spectrophotomety 
3) Visible spectrophotometry 
a) Method – I (using MBTH reagent) 
b) Method – II (using potassium ferricyanide) 
4) HPTLC  
4.2.1 UV Spectroscopic Method 
4.2.1.1 Selection of solvent 
             The solubility of Tapentadol Hydrochloride was determined in a variety of 
solvents as per Indian pharmacopoeia standards. Solubility was carried out in polar and 
non polar solvents. From the solubility data distilled water was selected as solvent for 
the analysis of Tapentadol Hydrochloride. 
4.2.1.2 Preparation of standard stock solution 
 25 mg of Tapentadol Hydrochloride raw material was weighed accurately and 
transferred in to 25 ml volumetric flask, dissolved in distilled water and made up to the 
volume with distilled water. This solution contains 1mg/ ml concentration.  
4.2.1.3 Selection of wavelengths for estimation and stability studies 
 The standard stock solution was further diluted with distilled water to get the 
concentration of 10 µg/ ml and the solution was scanned between 200 and 400 nm using 
distilled water as blank. From the spectra, λmax
 
was found to be 272.5 nm and was 
selected as an analytical wavelength.  
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 The stability was performed by measuring the solution at different time 
intervals. It was observed that Tapentadol Hydrochloride in distilled water was stable 
up to 24 hours at the selected wavelength. 
4.2.1.4 Preparation of calibration graph 
 The standard stock solution of Tapentadol Hydrochloride (1–6 ml) was 
transferred into a series of 100 ml volumetric flasks and made up to the volume with 
distilled water. The absorbance of different concentration solutions were measured at 
272.5 nm. The calibration curve was constructed by plotting concentration Vs
 
absorbance. Tapentadol Hydrochloride was linear with the concentration range of       
10 - 60 µg/ ml at 272.5 nm. 
4.2.1.5 Quantification of raw material 
 2.0 ml of standard stock solution was taken into a series of six 100 ml standard 
flasks and the volume was made up to mark with distilled water. The absorbance of 
these solutions was measured at 272.5 nm. The amount Tapentadol Hydrochloride 
present in the raw material was determined by using slope and intercept values from 
calibration graph.   
4.2.1.6 Quantification of formulation 
 Ten tablets of formulation (Tapol-100 containing Tapentadol Hydrochloride 
equivalent to 100 mg) were weighed accurately and the average weight of each tablet 
was found. The tablets were ground to a fine powder. The tablet powder equivalent to 
25 mg of Tapentadol Hydrochloride was weighed and transferred into 25 ml volumetric 
flask. Added about 20 ml of distilled water to dissolve the substance and the solution 
was sonicated for 15 minutes. Then it was made up to the volume to 25 ml with distilled 
water (1 mg/ ml) and centrifuged for 15 minutes. The supernatant liquid was filtered 
through Whatmann filter paper No. 41. From the clear solution, further dilutions were 
66 
 
made by diluting 2.0 ml into 100 ml with distilled water to obtain 20 µg/ ml solution 
theoretically. The absorbances of six replicates were measured and the amount was 
calculated by using regression equation. This procedure was repeated for six times. 
4.2.1.7 Recovery studies 
4.2.1.7.1 Preparation of Tapentadol Hydrochloride raw material stock solution 
 250 mg of Tapentadol Hydrochloride was accurately weighed and transferred 
into 25 ml Volumetric flask and sufficient distilled water was added to dissolve the 
substance and made up to the mark with the same. This contains 10 mg/ ml 
concentration.  
4.2.1.7.2 Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Tapentadol Hydrochloride to the pre-analyzed formulation. 
The tablet powder equivalent to 25 mg of Tapentadol Hydrochloride was weighed 
accurately and added 2 ml, 2.5 ml, 3 ml of above raw material stock solution into a 
series of 25 ml volumetric flasks and dissolved with distilled water and sonicated for  
15 minutes. The solution was made up to 25 ml with distilled water and centrifuged for 
15 minutes at 2000 rpm. The supernatant liquid was filtered through a Whatmann filter 
paper No.41. 2 ml of the clear solution was transferred into 100 ml volumetric flask and 
made up to 100 ml with distilled water. The absorbance of three replicates was 
measured at the selected wavelength. The amount of drug recovered from formulation 
was calculated. The procedure was repeated for three times for each concentration.  
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4.2.1.8 Validation of developed method  
4.2.1.8.1 Linearity 
 A calibration curve was plotted between concentration and absorbance. 
Tapentadol Hydrochloride was linear in the concentration range of 10 - 60 µg/ ml at 
272.5 nm. The optical characteristics were calculated. 
4.2.1.8.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated. The percentage RSD and confidence interval 
were calculated. 
 The intermediate precision of the method was confirmed by intraday and inter 
day analysis i.e. the analysis of formulation was repeated three times in the same day 
and on three successive days. The amount of drugs present in the formulation was 
determined. The percentage RSD and confidence interval were calculated.     
4.2.1.8.3 Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation, a known quantity of raw material of Tapentadol Hydrochloride was added 
and the procedure was followed as per the analysis of formulation. The amount of each 
drug recovered was calculated. This procedure was repeated for three times for each 
concentration. The % RSD and confidence interval were calculated. 
4.2.1.8.4 Ruggedness  
 Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount was calculated. 
The % RSD and confidence interval were calculated. 
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4.2.1.8.5 LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results still 
satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet 
these criteria (analysis is not feasible). It may expressed as 
   
LOD =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
 The limit of quantitation (LOQ) is set at a higher concentration than LOD, in the 
statistical method, it is 10 SD above the mean blank value, this presenting a greater 
probability that a value at the LOQ is real and not just a random fluctuation of the blank 
reading.  
LOQ = 
     10 σ 
         S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
4.2.2 Difference Spectrophotomeric Method 
 The difference spectrophotometric method is based on the measurement of 
amplitude between maxima and minima in two eqimolar solutions of the analyte in 
different chemical forms, which exhibit different spectral characteristics. The method is 
advantageous over others, as it achieves the spectrophotometric isolation of the drug; 
moreover, interference due to additives can be nullified as can be proved by no change 
in isobestic points. 
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4.2.2.1 Selection of solvent 
 Distilled water, 0.1M hydrochloric acid and 0.1M sodium hydroxide were 
selected as the solvent after considering the solubility and stability factors of the drug as 
well as excipients present in tablet formulation. 
4.2.2.2 Preparation of standard stock solution 
 30 mg of Tapentadol Hydrochloride was accurately weighed and transferred in 
to 100 ml volumetric flask and added about 80 ml of distilled water to dissolve the drug. 
After the immediate dissolution, the volume was made up to the mark with distilled 
water. The solution was observed to contain 300 µg / ml. 
4.2.2.3 Selection of wave length for estimation and stability studies 
  The selection of wavelengths for the estimation of Tapentadol Hydrochloride 
was done by preparing a solution containing 10 µg/ ml of Tapentadol Hydrochloride in 
0.1M sodium hydroxide and 0.1M hydrochloric acid separately. The difference spectra 
were recorded by taking Tapentadol Hydrochloride in 0.1M hydrochloric acid as blank 
and Tapentadol Hydrochloride in 0.1M sodium hydroxide as sample. From the 
difference spectra, 290 nm and 269.5 nm were selected as maxima and minima, 
respectively. The measured value is the amplitude between the two equimolar solutions 
of the analyte in difference chemical forms, which exhibits different spectral 
characteristics. Tapentadol hydrochloride in 0.1M sodium hydroxide was stable up to 4 
hours and in 0.1M hydrochloric acid was stable up to 31/2 hours. 
4.2.2.4 Preparation of calibration graph 
 The aliquots of the 300 µg/ ml standard stock solution of Tapentadol 
Hydrochloride in distilled water (1 to 6 ml) were transferred in to two sets of series of 
100 ml volumetric flasks. The first set of Tapentadol Hydrochloride solutions were 
diluted to 100 ml with 0.1N Hydrochloric acid, and the second set of Tapentadol 
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Hydrochloride solutions were diluted to 100 ml with 0.1N Sodium hydroxide. 
Difference spectrum was recorded by placing same concentration of acidic and basic 
solutions in reference and sample cells respectively. The procedure was repeated for six 
times, the amplitude was plotted against concentration. 
4.2.2.5 Quantification of raw material 
 Six times the concentration of Tapentadol Hydrochloride raw material solution 
(12 µg/ ml) was prepared from the stock solution in 0.1M sodium hydroxide and    
0.1M hydrochloric acid. Tapentadol Hydrochloride (12 µg/ ml) in 0.1M sodium 
hydroxide is kept in sample cell and Tapentadol Hydrochloride (12 µg/ ml) in         
0.1M hydrochloric acid is kept in reference cell. The amplitude between the equimolar 
concentrations was measured. The concentration of Tapentadol Hydrochloride was 
determined by using slope and intercept values from calibration values. 
4.2.2.6 Quantification of formulation 
 Twenty tablets (Tapol-100 containing Tapentadol Hydrochloride equivalent to 
100 mg) were weighed accurately and the average weight was found. The tablets were 
ground to a fine powder. The weight of tablet pwder equivalent to 30 mg of Tapentadol 
Hydrochloride was taken in 100 ml volumetric flask. It was then dissolved in distilled 
water by intermittent shaking for 4 – 5 minutes. The solution was sonicated for            
15 minutes. Then it was made up to the volume 100 ml with distilled water, and 
centrifuged at 2000 rpm for 15 minutes and the solution were filtered through whatman 
filter paper (No.41). 
4.2.2.6.1 Assay procedure 
 Six times the concentration of Tapentadol Hydrochloride test solution             
(12 µg/ ml) was prepared from the above solution (4 ml into 100 ml) in 1M sodium 
hydroxide and in 0.1M hydrochloric acid. Tapentadol Hydrochloride (12 µg/ ml) in 
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0.1M hydrochloric acid was kept in reference cell and Tapentadol Hydrochloride        
(12 µg/ ml) in 0.1M sodium hydroxide was kept in sample cell. The amplitude between 
the equimolar solutions was measured. The concentration of Tapentadol Hydrochloride 
was determined by using slope and intercept values from calibration graph. 
4.2.2.7 Recovery studies 
4.2.2.7.1 Preparation of Tapentadol Hydrochloride raw material stock solution 
    150 mg of Tapentadol Hydrochloride raw material was accurately weighed 
and 10 ml Volumetric flask and sufficient distilled water was added to dissolve the 
substance and made up to the mark with the same. This contains 15 mg/ ml 
concentration. 
4.2.2.7.2 Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Tapentadol Hydrochloride to the preanalyzed formulation. 
The tablet powder equivalent to 30 mg of Tapentadol Hydrochloride was weighed 
accurately and added 1.5 ml, 2.0 ml and 2.5 ml of above raw material stock solution 
into a series of 100 ml volumetric flasks and dissolved with distilled water, sonicated 
for 15 minutes. The solution was made up to 100 ml with distilled water and 
centrifuged for 15 minutes at 2000 rpm. The supernatant liquid was filtered through a 
Whatmann filter paper No.41. From the above solution 2.0 ml was transferred into two 
100 ml volumetric flasks and one was made up to 100 ml with 0.1N sodium hydroxide 
and another one was made up with 0.1N hydrochloric acid. The procedure was reported 
as per the analysis of formulation. This procedure was repeated for three times for each 
concentration.  
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4.2.2.8 Validation of developed method  
4.2.2.8.1 Linearity 
 A calibration curve was plotted between concentration and amplitude. 
Tapentadol Hydrochloride was linear with the concentration range of 3 - 18 µg/ ml. 
4.2.2.8.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated. The percentage RSD and confidence interval 
were calculated. 
 The intermediate precision of the method was confirmed by intraday and inter 
day analysis i.e. the analysis of formulation was repeated three times in the same day 
and on three successive days. The amount of drugs was determined. The percentage 
RSD and confidence interval were calculated.     
4.2.2.8.3 Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation, a known quantity of raw material of Tapentadol Hydrochloride was added 
and the procedure was followed as per the analysis of formulation. The amount of each 
drug recovered was calculated. This procedure was repeated for three times for each 
concentration. The % RSD and confidence interval were calculated. 
4.2.2.8.4 Ruggedness  
 Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount was calculated. 
The % RSD and confidence interval were calculated. 
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4.2.2.8.5 LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results still 
satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet 
these criteria (analysis is not feasible). It may expressed as 
   
LOD =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
 The limit of quantitation (LOQ) is set at a higher concentration than LOD, in the 
statistical method, it is 10 SD above the mean blank value, this presenting a greater 
probability that a value at the LOQ is real and not just a random fluctuation of the blank 
reading.  
LOQ = 
     10 σ 
         S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
4.2.3 Visible Spectrophotometric Methods 
4.2.3.1 Colorimetric method - I 
4.2.3.1.1 Principle (Burudi kalyanaramu et al., 2011; Yuan Cun-guang, 1988) 
 MBTH is a 3-Methyl-2-benzothiazolinone hydrazone hydrochloride 
monohydrate. MBTH reagnt is used for the estimation of drugs contain phenols, 
aromatic amines, aldehydes, polyhydroxy compounds, indoles, phenothiazones. With 
Phenols under reaction condition MBTH loses two electrons and one proton to form the 
electrophilic intermediate, which has been identified as the active coupling species that 
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undergoes electrophilic substitution with phenol and other groups to form the colored 
product. Para un-substituted phenols form orange red colour and para substituted 
phenols forms violet green with less intensity. Violet green coloured products are less 
stable than orange red coloured product. 
Figure: Schematic Reaction of Tapentadol Hydrochloride With MBTH Reagent 
 Tapentadol Hydrochloride have the para un-substituted phenol, and it react with 
MBTH reagent in the presence of oxidizing agent ceric ammonium sulphate in           
1M sulphuric acid and forms an orange red colored complex is formed which can be 
estimated by colorimetrically at 514 nm.  
4.2.3.1.2 Preparation of reagents 
 0.7% w/v of the MBTH was prepared by weighing 700 mg of the MBTH 
powder in to 100 ml volumetric flask, dissolved in 60 ml of water to dissolve and then 
made up to 100 ml with distilled water. 
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 0.01M ceric ammonium sulphate solution is prepared by weighing 0.6326 gm of 
ceric ammonium sulphate in to 100 ml volumetric flask and dissolved in 1M sulphuric 
acid and made up to the mark with 1M sulphuric acid. 
4.2.3.1.3 Preparation of standard stock solution 
 10 mg of the Tapentadol Hydrochloride raw material was transferred in to     
100 ml volumetric flask, dissolved in distilled water and made up to the volume to 100 
ml with distilled water. The solution contains 100 µg/ ml of Tapentadol Hydrochloride. 
4.2.3.1.4 Selection of wavelength for estimation and stability studies 
 2.5ml of the standard stock solution of Tapentadol Hydrochloride pipetted out in 
to 25 ml standard flask. To this added 1ml of 0.01M ceric ammonium sulphate solution 
and shaken well then added 0.8 ml of 0.7%w/v MBTH reagent with shaking. The 
volume was made up to the mark with distilled water to get concentration of 10 µg/ ml. 
The orange red coloured chromogen was scanned in visible region (400 – 800 nm) 
against reagent blank. From the spectra the λmax selected was 514 nm. 
 The stability was performed by measuring the absorbance of same solution at 
different time intervals. It was observed that Tapentadol Hydrochloride was stable up to 
four hours fifteen minutes at the selected wavelength. 
4.2.3.1.5 Optimization of reagents 
 The absorbance of Tapentadol Hydrochloride in different strengths and 
volumes of both ceric ammonium sulphate and MBTH reagent were optimized to get 
steady absorbance. 
 The molarity of ceric ammonium sulphate was optimized by taking 2.5 ml of 
standard drug solution in to separate 25 ml volumetric flasks and added 1 ml of 
different molar solution of (0.002M - 0.02M) ceric ammonium sulphate and constant 
volume of 0.8 ml of 0.7% w/v MBTH reagent were added with shaking and made up to 
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the volume with distilled water. The absorbance of the solution in each standard flask 
was measured at 514 nm against reagent blank.  
 The volume of ceric ammonium sulphate solution was optimized by taking     
2.5 ml of standard drug solution (10 µg/ ml) in to separate 25 ml volumetric flasks and 
(0.1ml/ 1.5ml) of constant molarity of 0.01M ceric ammonium sulphate solution was 
added and constant volume of 0.8 ml of 0.7% w/v MBTH reagent were added with 
shaking and made up to the volume with distilled water. The absorbance of the solution 
in each standard flask was measured at 514 nm against reagent blank. 
 The strength of MBTH reagent was optimized by  taking 2.5 ml of standard drug 
solution (10 µg/ ml) in to separate 25 ml volumetric flasks, added a constant volume of 
1ml of 0.01M ceric ammonium sulphate and 0.8 ml of MBTH reagent of each strength 
(0.1% - 1.0%). The solutions were shaking and made up to the volume with distilled 
water. The absorbance of the solution in each standard flask was measured at 514 nm 
against reagent blank. 
 The volume of the MBTH reagent was optimized by taking 2.5 ml of standard 
drug solution in to separate 25 ml volumetric flasks in which constant volume of    1 ml 
of 0.01M ceric ammonium sulphate and (0.1 ml-1.2 ml) of 0.7% w/v of MBTH reagent 
were added with shaking and made up to the volume with distilled water. The 
absorbance of the solution in each standard flask was measured at 514 nm against 
reagent blank. 
 It was found that 1.0 ml of 0.01M ceric ammonium sulphate and 0.8 ml of   
0.7% w/v MBTH reagent were showed marked absorbance. 
4.2.3.1.6 Preparation of calibration graph 
 The standard stock solutions of Tapentadol Hydrochloride (0.5 ml – 6 ml) were 
transferred into a series of 25 ml volumetric flasks. To each flask, 1 ml of ceric 
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ammonium sulphate and 0.8 ml of 0.7% w/v of MBTH reagent were added with 
shaking and made up to the volume with distilled water. The absorbance of different 
concentration solutions were measured at 514 nm. The calibration curve was plotted. 
Tapentadol Hydrochloride was linear with the concentration range of 2-24 µg/ ml at 
 514 nm.  
4.2.3.1.7 Quantification of raw material 
 2.5 ml of standard stock solution of Tapentadol Hydrochloride was pipetted into 
a series of six 25 ml volumetric flasks, added 1 ml of ceric ammonium sulphate, 0.8 ml 
of 0.7% w/v of MBTH reagent, shaken well and the volume was made up to the mark 
with distilled water. The absorbances of the solutions were measured at 514 nm. This 
procedure was repeated for six times.    
4.2.3.1.8 Quantification of formulation  
 Twenty tablets of formulation (Tapol-100 containing Tapentadol Hydrochloride 
equivalent to 100 mg) were weighed accurately and the average weight of each tablet 
was found. The tablets were ground to a fine powder. The tablet powder equivalent to 
10 mg of Tapentadol Hydrochloride was weighed and transferred into 100 ml 
volumetric flask, added about 80 ml of distilled water to dissolve the substance and 
sonicated for 15 minutes. The solution was made up to the volume with distilled water 
(100 µg/ ml). The solution was centrifuged for 15 minutes at 2000 rpm and filtered 
through Whatmann filter paper No. 41. From the clear solution 2.5 ml was pipetted out 
into a series of six 25 ml volumetric flasks, added 1 ml of ceric ammonium sulphate,  
0.8 ml of 0.7% w/v of MBTH reagent with shaking and volume was made up to the 
mark with distilled water. The absorbances of the solutions were measured at 514 nm. 
This procedure was repeated for six times.    
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4.2.3.1.9 Recovery 
4.2.3.1.9.1 Preparation of Tapentadol Hydrochloride raw material stock solution 
 An accurately weighed quantity of 40 mg of Tapentadol Hydrochloride was 
transferred into 10 ml volumetric flask, added sufficient distilled water to dissolve the 
substance and made up to the volume with distilled water. The solution contains            
4 mg/ ml of Tapentadol Hydrochloride. 
4.2.3.1.9.2 Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Tapentadol Hydrochloride to the preanalyzed formulation. To 
the tablet powder equivalent to 10 mg of Tapentadol Hydrochloride, added 2 ml, 2.5 ml, 
and 3 ml of above raw material stock solution in to a series of three 100 ml standard 
flasks, dissolved in distilled water and sonicated for 15 minutes. The solution was made 
up to 100 ml with distilled water. The solution was centrifuged for 15 minutes at 2000 
rpm and the solution was filtered through a Whatmann filter paper No.41. 2.5 ml of the 
clear solution was transferred in to a series of six 25 ml volumetric flasks, added 1 ml of 
ceric ammonium sulphate, 0.8 ml of 0.7% w/v of MBTH reagent and the volume was 
made up to the mark with distilled water. The absorbances of these solutions were 
measured at 514 nm. This procedure was repeated for three times.    
4.2.3.1.10 Validation of developed method  
4.2.3.1.10.1 Linearity 
 A calibration curve was plotted between concentration and amplitude. 
Tapentadol Hydrochloride was linear with the concentration range of 2 - 24 µg/ ml. 
4.2.3.1.10.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
79 
 
the tablet formulation was calculated. The percentage RSD and confidence interval 
were calculated. 
 The intermediate precision of the method was confirmed by intraday and inter 
day analysis i.e. the analysis of formulation was repeated three times in the same day 
and on three successive days. The amount of drugs was determined. The percentage 
RSD and confidence interval were calculated.     
4.2.3.1.10.3 Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation, a known quantity of raw material of Tapentadol Hydrochloride was added 
and the procedure was followed as per the analysis of formulation. The amount of each 
drug recovered was calculated. This procedure was repeated for three times for each 
concentration. The % RSD and confidence interval were calculated. 
4.2.3.1.10.4 Ruggedness  
 Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount was calculated. 
The % RSD and confidence interval were calculated. 
4.2.3.1.10.5 LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results still 
satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet 
these criteria (analysis is not feasible). It may expressed as 
   
LOD =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
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 The limit of quantitation (LOQ) is set at a higher concentration than LOD, in the 
statistical method, it is 10 SD above the mean blank value, this presenting a greater 
probability that a value at the LOQ is real and not just a random fluctuation of the blank 
reading.  
LOQ = 
     10 σ 
         S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
4.2.3.2 Colorimetric method-II 
4.2.3.2.1 Principle (Adhikamsetty R. K. et al., 2009) 
 Tapentadol Hydrochloride in acidic medium combines with potassium 
ferricyanide and ferric chloride forms water insoluble coloured complex called prussion 
blue with maximum absorbance at 737 nm. This Prussian blue colored substance is 
insoluble in acidic media but it is soluble in alkali. 
4.2.3.2.1.1 Reaction 
Tapentadol 
hydrochloride 
+ K3Fe(CN)6 
Potassium 
ferricyanide 
 
Fe4[Fe(CN)6]3 
Ferric 
frrocyanide 
4.2.3.2.2 Preparation of reagent 
 0.5% w/v of the ferric chloride was prepared by weighing 500 mg of the ferric 
chloride in to 100 ml volumetric flask and dissolved in distilled water to dissolve and 
then made up to 100 ml with distilled water. 
 0.1% w/v potassium ferricyanide solution is prepared by weighing 100 gm of 
potassium ferricyanide in to 100 ml volumetric flask and dissolved in distilled water 
and made up to 100 ml with distilled water. 
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 1M hydrochloric acid may be prepared by diluting 8.5 ml of hydrochloric acid 
to 100 ml with distilled water. (I.P 2007) 
4.2.3.2.3 Preparation of standard stock solution 
 100 mg of the Tapentadol Hydrochloride raw material was transferred in to   
100 ml volumetric flask, about 80 ml of distilled water was added to dissolve the 
substance and made up to 100 ml with distilled water. The solution contains 1 mg/ ml of 
Tapentadol Hydrochloride. 
4.2.3.2.4 Preparation of working standard solution 
 From the stock solution, 5 ml was pipetted out in to a 100 ml volumetric flask. 
The volume was made up to 100 ml with distilled water. The solution contains            
50 µg/ ml of Tapentadol Hydrochloride solution.  
4.2.3.2.5 Selection of wavelength for estimation and stability studies 
 2 ml of the working standard solution of Tapentadol Hydrochloride was pipetted 
out in to 25 ml volumetric flask. To this 1.5 ml of 0.5% w/v solution of ferric chloride 
solution was added and shaken well for 2 minutes. Then 3.2 ml of 0.1% w/v solution of 
potassium ferricyanide was added, shaken well and kept aside for another 2 minutes. To 
this solution, 2.5 ml of 1M hydrochloric acid was added and allowed to stand for further 
2 minutes. The volume was made up to the mark with distilled water to get 
concentration of 10 µg/ ml. The spectrum was recorded in the range of 400 – 800 nm 
against reagent blank. From the spectra the wavelength (λmax) selected was 737 nm. 
 The stability was performed by measuring the absorbance of the same solution 
at different time intervals. It was observed that Tapentadol Hydrochloride was stable up 
to five hours at the selected wavelength. 
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4.2.3.2.6 Optimization of reagents 
 The absorbance of Tapentadol Hydrochloride in different strengths and volumes 
of ferric chloride, potassium ferricyanide and 1M hydrochloric acid were measured to 
optimize the reagents. 
  The strength of ferric chloride was optimized by taking 2 ml of working 
standard solution in to separate 25 ml volumetric flasks and added 1.5 ml of different 
concentrations of (0.1%-1.0%) ferric chloride and shaken well for 2 minutes. Then     
3.2 ml of 0.1%w/v solution of potassium ferricyanide was added and allowed to stand 
for 2 minutes. To this, 2.5 ml of 1M hydrochloric acid was added and kept aside for 
another 2 minutes, and made up to 25 ml with distilled water. The absorbance of the 
solution in each flask was measured at 737 nm against reagent blank.  
 The volume of 0.5% w/v ferric chloride solution was optimized by taking 2 ml 
of working standard drug solution (4 µg/ ml) in to separate 25 ml volumetric flasks and 
added 0.5% w/v solution of ferric chloride in different volumes (0.1 ml – 2 ml) and 
shaken for 2 minutes. Then 3.2 ml of 0.1% w/v solution of potassium ferricyanide was 
added, shaken well and kept aside for another 2 minutes. To this solution, 2.5 ml of                
1M hydrochloric acid was added and allowed to stand for further 2 minutes, and made 
up to 25 ml with distilled water. The absorbance of the solution in each flask was 
measured at 737 nm against reagent blank. 
  The strength of potassium ferricyanide was optimized by taking 2 ml of working 
standard drug solution (4 µg/ml) in to separate 25 ml volumetric flasks, added a 
constant volume of 1.5 ml of 0.5% w/v solution of ferric chloride and shaken for           
2 minutes. Then 3.2 ml of different strengths of (0.01% - 0.15%) potassium ferricyanide 
solution were added, shaken well and kept aside for another 2 minutes. To this solution, 
2.5 ml of 1M hydrochloric acid was added and allowed to stand for further 2 minutes, 
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and made up to 25 ml with distilled water. The absorbance of the solution in each flask 
was measured at 737 nm against reagent blank. 
 The volume of the of 0.1% w/v solution of potassium ferricyanide was 
optimized by taking 2 ml of working standard drug solution (4 µg/ ml) in to separate   
25 ml volumetric flasks and added a constant volume of 1.5 ml of 0.5% w/v solution of 
ferric chloride and shaken for 2 minutes. Added 0.1% w/v solution of potassium 
ferricyanide in different volumes (0.2 ml-4 ml), shaken well and kept aside for another 
2 minutes. To this solution, 2.5 ml of 1M hydrochloric acid was added and allowed 
stand for further 2 minutes, and made up to 25 ml with distilled water. The absorbance 
of the solution in each flask was measured at 737 nm against reagent blank. 
 The strength of hydrochloric acid was optimized by taking 2 ml of working 
standard drug solution (4 µg/ml) in to separate 25 ml volumetric flasks and added a 
constant volume of 1.5 ml of 0.5% w/v solution of ferric chloride and shaken for           
2 minutes. Then 3.2 ml of 0.1% w/v solution of potassium ferricyanide was added, 
shaken well and kept aside for another 2 minutes. To this solution, added 2.5 ml of each 
strength of (0.2M-2.0M) hydrochloric acid and allowed stand for further 2 minutes, and 
made up to 25 ml with distilled water. The absorbance of the solution in each flask was 
measured at 737 nm against reagent blank. 
 The strength of hydrochloric acid was optimized by taking 2 ml of working 
standard drug solution (4 µg/ml) in to separate 25 ml volumetric flasks and added a 
constant volume of 1.5 ml of 0.5% w/v solution of ferric chloride and shaken for           
2 minutes. Then 3.2 ml of 0.1% w/v solution of potassium ferricyanide was added, 
shaken well and kept aside for another 2 minutes. To this solution, added different 
volumes of (0.5ml-5.0ml) 1M hydrochloric acid and allowed to stand for further           
84 
 
2 minutes, and made up to 25 ml with distilled water. The absorbance of the solution in 
each flask was measured at 737 nm against reagent blank. 
 It was found that 1.5 ml of 0.5% w/v solution of ferric chloride, 3.2 ml of    
0.1% w/v solution of potassium ferricyanide and 2.5 ml of 1M hydrochloric acid were 
showed marked absorbance. 
4.2.3.2.7 Preparation of calibration graph 
 The working standard solutions of Tapentadol Hydrochloride (0.5ml – 5ml) 
were transferred into a series of 25 ml volumetric flasks. To each flask, 1.5 ml of 0.5% 
w/v solution of ferric chloride and shaken for 2 minutes. Then 3.2 ml of 0.1% w/v 
solution of potassium ferricyanide was added, shaken well and kept aside for another    
2 minutes. To this solution, 2.5 ml of 1M hydrochloric acid was added and allowed to 
stand for further 2 minutes, and made up to 25 ml with distilled water. The absorbance 
of different concentration solutions were measured at 737 nm. The calibration curve 
was plotted. Tapentadol Hydrochloride was linear with the concentration range of        
1-10 µg/ ml at 737 nm.  
4.2.3.2.8 Quantification of raw material 
 2 ml of working standard solution of Tapentadol Hydrochloride was pipetted 
into a series of six 25 ml volumetric flasks, added 1.5 ml of 0.5% w/v solution of ferric 
chloride and shaken for 2 minutes. Then 3.2 ml of 0.1% w/v solution of potassium 
ferricyanide was added, shaken well and kept aside for another 2 minutes. To this 
solution, 2.5 ml of 1M hydrochloric acid was added and allowed to stand for further      
2 minutes, and made up to 25 ml with distilled water. The absorbances of the solutions 
were measured at 737 nm. This procedure was repeated for six times.    
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4.2.3.2.9 Quantification of formulation  
 Twenty tablets of formulation (Tapol-100 containing Tapentadol Hydrochloride 
equivalent to 100 mg) were weighed accurately and the average weight of each tablet 
was found. The tablets were ground to a fine powder. The tablet powder equivalent to 
100 mg of Tapentadol Hydrochloride was weighed and transferred into 100 ml 
volumetric flask, added about 80 ml of distilled water to dissolve the substance and 
sonicated for 15 minutes. The solution was made up to the volume with distilled water 
(100 µg/ ml). The solution was centrifuged for 15 minutes at 2000 rpm and filtered 
through Whatmann filter paper No. 41. From the clear solution, 5 ml was diluted to   
100 ml with distilled water to get the concentration of 50 µg/ ml of Tapentadol 
Hydrochloride. Further 2 ml was pipetted out in to a series of six 25 ml volumetric 
flasks, added 1.5 ml of 0.5% w/v solution of ferric chloride and shaken for 2 minutes. 
Then 3.2 ml of 0.1% w/v solution of potassium ferricyanide was added, shaken well and 
kept aside for another 2 minutes. To this solution, 2.5 ml of 1M hydrochloric acid was 
added and allowed to stand for further 2 minutes, and made up to 25 ml with distilled 
water. The absorbances of solutions were measured at 737 nm. This procedure was 
repeated for six times.    
4.2.3.2.10 Recovery  
4.2.3.2.10.1 Preparation of Tapentadol Hydrochloride raw material stock solution 
 An accurately weighed quantity of 400 mg of Tapentadol Hydrochloride was 
transferred into 10 ml volumetric flask, added sufficient distilled water to dissolve the 
substance and made up to the volume to 10 ml with distilled water. The solution 
contains 40 mg/ ml of Tapentadol Hydrochloride. 
 
 
86 
 
4.2.3.2.10.2 Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Tapentadol Hydrochloride to the preanalyzed formulation. 
The tablet powder equivalent to 100 mg of Tapentadol Hydrochloride was weighed in 
to three separate 100 ml volumetric flasks. To this added 2 ml, 2.5 ml and 3 ml of 
Tapentadol Hydrochloride raw material stock solution. Added about 80 ml of distilled 
water and sonicated for 15 minutes. The solution was made up to 100 ml with distilled 
water. The solution was centrifuged for 15 minutes at 2000 rpm and the solution was 
filtered through a Whatmann filter paper No.41. From the clear solution, 5 ml of the 
clear solution was transferred in to a series of 100 ml volumetric flasks. Further 2 ml 
was pipetted out in to a series of 25 ml volumetric flasks, added 1.5 ml of 0.5% w/v 
solution of ferric chloride and shaken for 2 minutes. Then 3.2 ml of 0.1% w/v solution 
of potassium ferricyanide was added, shaken well and kept aside for another 2 minutes. 
To this solution, 2.5 ml of 1M hydrochloric acid was added and allowed to stand for 
further 2 minutes, and made up to 25 ml with distilled water. The absorbances of 
solutions were measured at 737 nm. This procedure was repeated for three times.    
4.2.3.2.11 Validation of developed method  
4.2.3.2.11.1 Linearity 
 A calibration curve was plotted between concentration and amplitude. 
Tapentadol Hydrochloride was linear with the concentration range of 1 - 10 µg/ ml. 
4.2.3.2.11.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated. The percentage RSD and confidence interval 
were calculated. 
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 The intermediate precision of the method was confirmed by intraday and inter 
day analysis i.e. the analysis of formulation was repeated three times in the same day 
and on three successive days. The amount of drugs was determined. The percentage 
RSD and confidence interval were calculated.     
4.2.3.2.11.3 Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation, a known quantity of raw material of Tapentadol Hydrochloride was added 
and the procedure was followed as per the analysis of formulation. The amount of each 
drug recovered was calculated. This procedure was repeated for three times for each 
concentration. The % RSD and confidence interval were calculated. 
4.2.3.2.11.4 Ruggedness  
 Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount was calculated. 
The % RSD and confidence interval were calculated. 
4.2.3.2.11.5 LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results still 
satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet 
these criteria (analysis is not feasible). It may expressed as   
LOD =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
 The limit of quantitation (LOQ) is set at a higher concentration than LOD, in the 
statistical method, it is 10 SD above the mean blank value, this presenting a greater 
probability that a value at the LOQ is real and not just a random fluctuation of the blank 
reading.  
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LOQ = 
     10 σ 
         S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve. 
4.2.4 HPTLC Method 
In HPTLC, the separation of the components of a mixture is based upon the 
principle of adsorption. HPTLC is differ from the TLC in the size of the silica gel used 
as the stationary phase, automated sampling application and detection. In the present 
study, a twin trough chamber and silica gel 60 F 254 plates were used. 
4.2.4.1 Optimization of chromatographic method 
The initial separation conditions used for the separation of Tapentadol 
Hydrochloride as follows. 
Stationary Phase  - Silica gel 60 F 254 HPTLC Plates 
Mobile Phase   - Methanol : Ethyl acetate : Hexane 
Ratio    - 8 : 1 : 1 % v/v/v 
Detection    - UV light 
Temperature   - Room temperature 
Chamber    - Camag Twin Trough Chamber 
Development Mode   - Ascending Mode 
The mobile phase was allowed to saturate for 20 minutes in the chamber. A 
1mg/ ml solution was spotted on the plates and developed inside the saturated chamber. 
4.2.4.2 Selection of Mobile Phase 
Different mixtures of mobile phase were tried to choose the best mobile phase 
for the analysis. They include the following 
n-butanol: Methanol :Ammonia (5:4:1 % v/v/v) 
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Ethanol: Ethyl Acetate: Water (6:3:1 % v/v/v) 
Ethanol: Hexane: Water (7:1:2 % v/v/v) 
Ethanol: Toluene: Water (7:1:2 % v/v/v) 
n-butanol: Methanol: Ammonia (5:4:1 % v/v/v) 
n-butanol: Methanol: Ammonia (3:6:1 % v/v/v) 
n-butanol: Methanol: Ammonia (6:3:1 % v/v/v) 
n-butanol: Methanol: Ammonia (7:2:1 % v/v/v) 
Methanol: Ethyl acetate: Water (9:0.5:0.5 % v/v/v) 
Methanol: Ethyl acetate: Water (8:1:1 % v/v/v) 
Methanol: Ethyl acetate: Water (7:2:1 % v/v/v) 
Methanol: Ethyl acetate: Water (6:3:1 % v/v/v) 
From the above list of mobile phase the mobile phase Methanol: Ethyl acetate: 
Water (8:1:1 % v/v/v) was found to be a better mobile phase. The drug was eluted with 
good peak. 
4.2.4.3 Selection of detection wavelength 
 The spectrum of Tapentadol Hydrochloride was recorded in the selected mobile 
phase. 270 nm was selected as detection wave length (λ max, of Taapentadol 
Hydrochloride in Mobile phase) where the absorbance was maximum. 
4.2.4.4 Optimized Chromatographic Conditions 
After conforming with the mobile phase and the detection wavelength, the 
optimised conditions for the method was as follows, 
Stationary Phase - Silica Gel 60 F 254 HPTLC Plates 
Mobile Phase  - Methanol: Ethyl acetate: Water  
Ratio   - (8:1:1 % v/v/v) 
Detection  - CAMAG TLC Scanner 3, at 270 nm 
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Temperature  - Room Temperature 
Chamber  - CAMAG Twin Trough Chamber 
Development Mode - Ascending Mode 
4.2.4.5 Preparation of standard stock solution 
10 mg of Tapentadol Hydrochloride was weighed accurately and transferred into 
a 10 ml volumetric flask. Dissolved in methanol and the volume was made up to 10 ml 
with methanol to get a concentration of 1mg / ml. 
4.2.4.6 Preparation of working standard solution 
  From the stock solution, 1 ml was diluted to 10 ml with methanol. The solution 
contains 100 µg/ ml. 
4.2.4.7 Linearity and Calibration Curve 
Form the working standard solution, 1 - 6 µl were spotted at regular intervals in 
the plate to get a concentration range of 100 to 600 ng/ µl of Tapentadol Hydrochloride. 
The plates were developed and the calibration graph was plotted using peak area versus 
concentration. 
4.2.4.8 Quantification of formulation 
Twenty tablets were weighed accurately and the average weight of each tablet 
was determined. The tablets were crushed into fine powder. The tablet powder 
equivalent to 10 mg of Tapentadol Hydrochloride was weighed in to a 10 ml volumetric 
flask, dissolved in methanol and sonicated for 15 minutes and made up to 10 ml with 
methanol. This solution was centrifuged for 15 minutes at 2000 rpm. The solution was 
filtered through a Whatmann filter paper No. 41. From this solution, 1 ml was diluted to 
10 ml with methanol to get 100 ng/ µl of Tapentadol Hydrochloride. Six 3 µl spots were 
placed on the plates and the chromatograms were recorded. From the peak area the 
amount of the drug was calculated. 
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4.2.4.9 Recovery studies 
4.2.4.9.1 Preparation of Tapentadol Hydrochloride raw material stock solution 
40 mg of Tapentadol Hydrochloride raw material was weighed in to a 10 ml 
volumetric flask, dissolved well with methanol and made up to 10 ml with methanol to 
get the concentration of 4 mg/ ml. 
4.2.4.9.2 Procedure 
The recovery experiment was done by adding known concentrations of raw 
material stock solution of Tapentadol Hydrochloride to the preanalyzed formulation. 
Tablet powder equivalent to 10 mg of Tapentadol Hydrochloride was weighed in to 
three separate 10 ml volumetric flasks and dissolved in methanol, to this added 2 ml, 
2.5 ml and 3 ml of Tapentadol Hydrochloride raw material stock solution. Sonicated for        
15 minutes and made up to 10 ml with methanol. This solution was centrifuged for     
15 minutes at 2000 rpm. The solution was filtered through a Whatmann filter paper    
No. 41. From the clear solution, 1 ml was diluted to 10 ml with methanol. From this 
solution, 3 µl spot was placed from each flask and the chromatograms were recorded. 
The amount of drug recovered was calculated. The procedure was reported for three 
times. 
4.2.4.10 Validation of developed method  
4.2.4.10.1 Linearity 
 A calibration curve was plotted between concentration and amplitude. 
Tapentadol Hydrochloride was linear with the concentration range of 100 - 600 ng/ µl. 
4.2.4.10.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
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the tablet formulation was calculated. The percentage RSD and confidence interval 
were calculated. 
 The intermediate precision of the method was confirmed by intraday and inter 
day analysis i.e. the analysis of formulation was repeated three times in the same day 
and on three successive days. The amount of drugs was determined. The percentage 
RSD and confidence interval were calculated.     
4.2.4.10.3 Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation, a known quantity of raw material of Tapentadol Hydrochloride was added 
and the procedure was followed as per the analysis of formulation. The amount of each 
drug recovered was calculated. This procedure was repeated for three times for each 
concentration. The % RSD and confidence interval were calculated. 
4.2.4.10.4 LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results still 
satisfy some predetermined acceptance criteria. Below the LOD, the results fail to meet 
these criteria (analysis is not feasible). It may expressed as   
LOD =       3.3 σ 
            S 
Where,    σ = the standard deviation of the response 
   S = the slope of the calibration curve 
 The limit of quantitation (LOQ) is set at a higher concentration than LOD, in the 
statistical method, it is 10 SD above the mean blank value, this presenting a greater 
probability that a value at the LOQ is real and not just a random fluctuation of the blank 
reading.  
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LOQ = 
     10 σ 
         S 
Where,    σ = the standard deviation of the response 
      S = the slope of the calibration curve. 
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5. RESULTS AND DISCUSSION 
The following methods were developed and validated for the estimation of 
Tapentadol Hydrochloride in pure and in tablet dosage form. The methods are 
1) UV spectroscopic method 
2) Difference spectrophotometric method 
3) Visible spectrophotometric method  
a) Method – I (using MBTH reagent) 
b) Method – II (using potassium ferricyanide) 
4) HPTLC method 
5.1. UV SPECTROSCOPIC METHOD  
Tapentadol Hydrochloride was obtained as a gift sample from MSN 
Laboratories Limited, Hyderabad and was identified by melting point analysis and      
IR spectral studies (figure 1). 
  The solubility of Tapentadol Hydrochloride was determined as per Indian 
pharmacopoeia (table -1). The number of polar and non - polar solvents were tried to 
dissolve the drug. From the solubility data Tapentadol Hydrochloride is very soluble in 
Distilled water, 0.1M Hydrochloric Acid, pH-3.0 (Acid Phthalate Buffer), pH-5.0 
(Neutralized Phthalate Buffer), pH-7.0 (Phosphate Buffer), pH-9 (Alkaline Borate 
Buffer); freely soluble in Methanol, Ethanol, Di Methyl Formamide,  Acetic Acid,  
Pyridine; soluble in n-Butanol; sparingly soluble in 0.1M Sodium hydroxide, Iso Propyl 
Alcohol; slightly soluble in Acetonitrile, Ethyl  Acetate, Dichloromethane, Toluene and 
practically in soluble in Acetone, Chloroform, Benzene, Diethyl ether. From the 
solubility profile, Distilled water, 0.1M Hydrochloric acid, pH-3.0 (Acid Phthalate 
Buffer), pH-5.0 (Neutralized Phthalate Buffer), pH-7.0 (Phosphate Buffer), pH-9 
(Alkaline Borate Buffer) can be used as solvents. But when compared to distilled water, 
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the other solvents to be prepared before using. Preparations of such solvents are time 
consuming. Even though the cut off wave length for distilled water is very low (205 
nm) when compared to other solvents. Hence distilled water was selected as solvent for 
the analysis of Tapentadol Hydrochloride. 
 The spectrum of Tapentadol Hydrochloride was recorded in the wavelength 
range of 200 – 400 nm. From the spectrum, the maximum absorbance was observed at 
272.5 nm. Hence 272.5 nm was selected for the analysis of Tapentadol Hydrochloride. 
This is shown figure 2. The stability of Tapentadol Hydrochloride was studied by 
measuring the absorbance at different time intervals. It was observed that the drug was 
stable up to 24 hours in distilled water.  
Different aliquots of Tapentadol Hydrochloride were prepared in the 
concentration range of 10 to 60 µg/ ml. The absorbances of solutions were measured at 
272.5 nm. The calibration curve was plotted using concentration against absorbance. 
The preparation of calibration curve was repeated for six times. The optical 
characteristics like Correlation coefficient, Slope, Intercept, Molar absorptivity, 
Sandell’s sensitivity, LOD, LOQ and Residual sum of squares were calculated. The 
correlation coefficient value for the calibration graph was found to be 0.9999. This 
indicates that the absorbance were linear with the concentration range of                      
10 – 60 µg/ ml. The calibration curve of Tapentadol Hydrochloride is shown in figure 3. 
The optical characteristics are listed in table 2.                  
 To confirm the developed method, quantification of raw material was done and 
the amount was calculated. The percentage amount of Tapentadol Hydrochloride was 
found to be 98.21% ± 0.6159. The amount found by this method was close to 100%. 
Hence this method can be applied for analysis of formulation. The results are shown in 
table 3.  
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Tapol-100 tablets (MSN Laboratories Limited, Hyderabad) were selected for 
analysis. The nominal concentration of Tapentadol Hydrochloride from the linearity 
was prepared and the absorbance of the solution was measured at 272.5 nm. The 
amount of test solution was calculated by using slope and intercept values. This 
procedure was repeated for six times to ensure the precision of the method. The 
percentage label claim in tablet formulation was found to be 100.56 ± 0.3153. The 
amount present in tablet formulation was good concord with the label claim and the 
Percentage Relative Standard Deviation (% RSD) value was found to be 0.3136. The 
low % RSD value indicates that the method has good precision. The results of analysis 
are shown in table 4. 
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis of Tapentadol Hydrochloride was found to be 0.2781 and 0.3495, 
respectively. The reports of analysis are shown in tables 5 and 6. The results showed 
that the intermediate precision of the method was confirmed.  
The developed method was validated for Ruggedness. It refers to the analysis 
should be done in same laboratory which may include multiple analysts, multiple 
instruments and different sources of the reagents and so on. In the present work, it was 
confirmed by different analysts and different instrument. The percentage RSD value for 
analyst 1 and analyst 2 were found to be 0.3669 and 0.3980, respectively. The % RSD 
value for instrument 1 and instrument 2 were found to be 0.3538 and for 0.8992, 
respectively. The low % RSD values indicate that the method was more rugged. Reports 
of analysis are shown in tables 7 and 8 for different analyst and different instruments, 
respectively. 
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The accuracy of the method was confirmed by recovery studies. To the pre-
analyzed formulation a known quantity of Tapentadol Hydrochloride raw material 
solution was added at three different concentrations. The concentration of standard raw 
material added were 80%, 100% and 120% of the sample concentration. The 
absorbances of the solutions were measured and the percentage recovery was 
calculated.  The percentage recovery was found to be in the range of 100.46% to 
100.63% of Tapentadol Hydrochloride. The % RSD was found to be less than 2. The 
low % RSD values indicated that there are no interferences due to excipients used in 
formulation during the analysis of Tapentadol Hydrochloride from tablets formulation. 
Hence the method was found to be accurate. The recovery data are shown in table 9. 
5. 2 DIFFERENCE SPECTROSCOPIC METHOD  
 This method is based on the difference in absorbance measurements between the 
absorbance maxima and minima. It is a measure of amplitude between maxima and 
minima of two equimolar solutions of the Tapentadol Hydrochloride in different 
chemical forms, which exhibits different spectral characteristics. 
 Distilled water, 0.1M sodium hydroxide and 0.1 M hydrochloric acid were 
selected as solvents for difference spectroscopic method because of its easy availability, 
difference in pH, and high stability of Tapentadol Hydrochloride in all the solvents. 
The stock solution was prepared in distilled water. Then the difference spectrum 
was recorded by placing same concentration of further diluted Tapentadol 
Hydrochloride in 0.1M sodium hydroxide and 0.1M hydrochloric acid in sample and 
reference cell, respectively. The difference spectra of Tapentadol Hydrochloride were 
recorded as shown in figure 4. From the spectrum, Tapentadol Hydrochloride showed 
two maximas at 238 nm and 290 nm and one minima at 269.5 nm. In the maxima at  
238 nm, the interference due to solvent was obtained. Hence 290 nm was selected as the 
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maxima and 269.5 nm was selected as minima. The measured value was the amplitude 
between maxima and minima of two equimolar solutions in different chemical forms, 
which exhibits different spectral characteristics. Hence these wavelengths were selected 
for analysis of Tapentadol Hydrochloride by difference spectrophotometric method. 
 Serial dilutions of Tapentadol Hydrochloride were prepared in the 
concentrations range of 3-18 µg/ml in both 0.1M sodium hydroxide and                  
0.1M hydrochloric acid. The amplitude was measured the maxima at 290 nm and 
minima at 269.5 nm. The calibration curve was plotted using concentration versus 
amplitude. The procedure was repeated for six times. The optical parameters like 
correlation co-efficient, Slope, Intercept, Sandells sensitivity, Molar absorptivity, LOD, 
LOQ and Residual Sum of Square were calculated. These are shown in Table 10. The 
correlation co-efficient value was found to be 0.9999 indicates that the observed 
amplitude was linear with selected concentrations of Tapentadol Hydrochloride. The 
calibration graph is shown in figure 5. 
 To confirm the developed method, quantification of raw material was done and 
the amount was calculated. The percentage amount of Tapentadol Hydrochloride was 
found to be 100.84% ± 0.2562. The amount found by this method was close to 100%. 
Hence this method was applied for analysis of formulation. The results are shown in 
table 11. 
 Tapol-100 (MSN Laboratories Limited, Hyderabad) containing 100 mg 
of Tapentadol was selected for analysis. The nominal concentration of Tapentadol 
Hydrochloride from the linearity was prepared and the amplitude was measured at 
maxima at 290 nm and minima at 269.5 nm. The percentage of Tapentadol 
Hydrochloride present in tablet formulation was found to be 100.60 ± 0.5872. The 
amount present in tablet formulation was good concord with the label claim and the 
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Percentage Relative Standard Deviation (% RSD) value was found to be 0.5837. The 
low % RSD value indicates that the method has good precision. The results of analysis 
are shown in table 12. 
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis of Tapentadol Hydrochloride was found to be 0.3188 and 0.2667, 
respectively. The reports of analysis are shown in tables 13 and 14. The low % RSD 
values showing the intermediate precision of the method was confirmed.  
The developed method was validated for Ruggedness. It refers to the analysis 
should be done in same laboratory which may include multiple analysts, multiple 
instruments and different sources of the reagents and so on. In the present work, it was 
confirmed by different analysts and different instrument. The percentage RSD value for 
analyst 1 and analyst 2 was found to be 0.2364 and 0.4066, respectively. The % RSD 
value for instrument 1 and instrument 2 were found to be 0.7191 and 0.4620, 
respectively. The low % RSD values indicate that the method was more rugged. Reports 
of analysis are shown in tables 15 and 16 for different analysts and different 
instruments, respectively. 
The accuracy of the method was confirmed by recovery studies. To the pre-
analyzed formulation a known quantity of Tapentadol Hydrochloride raw material 
solution was added at three different concentrations. The concentrations of standard 
were 80%, 100% and 120% of the sample concentration. The absorbances of the 
solutions were measured and the percentage recovery was calculated.  The percentage 
recovery was found to be in the range of 98.37% to 99.04% of Tapentadol 
Hydrochloride. The % RSD was found to be less than 2. The low % RSD values 
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indicated that there are no interferences due to excipients used in formulation during the 
analysis of Tapentadol Hydrochloride from tablets formulation. Hence the method was 
found to be accurate. The recovery data are shown in table 17. 
5.3 VISIBLE SPECTROPHOTOMETRIC METHOD 
5.3.1 Colorimetric Method - I 
Tapentadol Hydrochloride has a phenolic hydroxyl group which is on treatment 
with MBTH reagent (3-Methyl-2-benzothiazolinone hydrazone hydrochloride 
monohydrate) in the presence of oxidizing agent (ceric ammonium sulphate) give a 
stable orange red coloured chromogen. The measurement of the intensity of coloured 
chromogen is the basis of this method. 
A solution of 10 µg/ ml was prepared from the stock solution and added 0.8ml 
of 0.1% w/v MBTH reagent and 1ml of 0.01M ceric ammonium sulphate was added 
with shaking, the solution was made up to the volume with distilled water. The intensity 
of the coloured solution was scanned in the visible region of   400 - 800 nm. The 
spectrum was recorded. The recorded spectra showed that at 514 nm Tapentadol 
Hydrochloride has the maximum absorbance. Hence this was selected as an analytical 
wavelength. This is shown in   figure 6. The optimizations of the reagents were done by 
measuring the absorbance of drug solution by adding different concentrations and 
volumes of ceric ammonium sulphate and MBTH reagent. The absorbance was plotted 
against different concentrations of ceric ammonium sulphate, different volumes of ceric 
ammonium sulphate and different concentrations of MBTH reagent, different volumes 
of MBTH reagent. These are shown in figures 7, 8, 9 and 10, respectively.  
From the study it was observed that addition of 1 ml of 0.01M ceric ammonium 
sulphate and 0.8 ml of 0.1% w/v MBTH reagent showed the maximum colour intensity. 
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Hence these are selected as the optimized concentrations and volumes of ceric 
ammonium sulphate and MBTH. 
Different aliquots of Tapentadol Hydrochloride were prepared in the 
concentration range of 2 to 24 µg/ ml. The absorbances of solutions were measured at 
514 nm. The calibration curve was plotted using concentration against absorbance. The 
preparation of calibration curve was repeated for six times. The optical characteristics 
like Correlation coefficient, Slope, Intercept, Molar absorptivity, Sandell’s sensitivity, 
LOD, LOQ and Residual Sum of Squares were calculated. The correlation coefficient 
value for the calibration graph was found to be 0.9991. This indicates that the 
absorbance were linear with the concentration range of 2 - 24 µg/ ml. The calibration 
curve of Tapentadol Hydrochloride is shown in figure 11. The optical characteristics are 
listed in table 18. 
To confirm the developed method, quantification of raw material was done and 
the amount was calculated. The percentage amount of Tapentadol Hydrochloride was 
found to be 101.08% ± 0.7682. The amount found by this method was close to 100%. 
Hence this method can be applied for the analysis of formulation. The results are shown 
in table 19.  
Tapol-100 tablets (MSN Laboratories Limited, Hyderabad), containing 100 mg 
of Tapentadol Hydrochloride) were selected for analysis. The nominal concentration of 
Tapentadol Hydrochloride from the linearity was prepared and the absorbance of the 
solution was measured at 514 nm. The amount of test solution was calculated by using 
slope and intercept valves. This procedure was repeated for six times to ensure the 
precision of the method. The percentage label claim in tablet formulation was found to 
be 100.05% ± 0.3318. The amount present in tablet formulation was good concord with 
the label claim and the Percentage Relative Standard Deviation (% RSD) value was 
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found to be 0.3317. The low % RSD value indicates that the method has good precision. 
The results of analysis are shown in table 20. 
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis of Tapentadol Hydrochloride was found to be 0.4819 and 0.2227, 
respectively. The reports of analysis are shown in tables 21 and 22, respectively. The 
results showed that the intermediate precision of the method was confirmed.  
The developed method was validated for Ruggedness. It refers to the analysis 
should be done in same laboratory which may include multiple analysts, multiple 
instruments and different sources of the reagents and so on. In the present work, it was 
confirmed by different analysts and different instrument. The percentage RSD value for 
analyst 1 and analyst 2 were found to be 0.1247 and 0.3622, respectively. The % RSD 
value for instrument 1 and for instrument 2 were found to be 0.3564 and 0.7566, 
respectively. The low % RSD values indicate that the method was more rugged. Reports 
of analysis are shown in tables 23 and 24 for different analysts and different 
instruments, respectively. 
The accuracy of the method was confirmed by recovery studies. To the 
preanalyzed formulation a known quantity of Tapentadol Hydrochloride raw material 
solution was added at three different concentrations. The concentrations of standard 
were 80%, 100% and 120% of the sample concentration. The absorbance of the 
solutions was measured and the percentage recovery was calculated.  The percentage 
recovery was found to be in the range of 101.23% to 101.87% of Tapentadol 
Hydrochloride. The % RSD values were found to be less than 2. The low % RSD values 
indicated that there is no interference due to excipients used in formulation during the 
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analysis of Tapentadol Hydrochloride from tablets formulation. Hence the method was 
found to be accurate. The recovery data are shown in table 25.  
5.3.2 Colorimetric Method - II 
 Tapentadol Hydrochloride has a phenolic hydroxyl group which is on treatment 
with ferric chloride and potassium ferricyanide in the presence of acidic medium give a 
stable Prussian blue coloured chromogen. The measurement of the intensity of coloured 
chromogen is the basis of this method. 
A solution of 4 µg/ ml was prepared from the stock solution and added 1.5 ml of 
0.5% w/v ferric chloride reagent with shaking for 2 minutes and 3.2 ml of 0.1% w/v 
potassium ferricyanide was added, kept aside for 2 minutes and then added 1ml of            
1M Hydrochloric acid stand for further 2 minutes, then the solution was made up to the 
volume with distilled water. The intensity of the coloured solution was scanned in the 
visible region of 400 - 800 nm. The spectrum was recorded. The recorded spectra 
showed that at 737 nm Tapentadol Hydrochloride has the maximum absorbance. Hence 
this was selected as an analytical wavelength. This is shown in   figure 12. 
The optimizations of the reagents were done by measuring the absorbance of 
drug solution by adding different concentrations and volumes of ferric chloride, 
Potassium ferricyanide and hydrochloric acid. The absorbance was plotted against 
different concentrations of ferric chloride and different volumes of ferric chloride, 
different concentrations of potassium ferricyanide, different volumes of potassium 
ferricyanide, and different concentrations of hydrochloric acid, different volumes of 
hydrochloric acid, and. These are shown in figures 13, 14, 15, 16, 17 and 18, 
respectively.  
From the study it was observed that addition of 1 ml of 0.5% w/v ferric chloride, 
3.2 ml of 0.1% w/v potassium ferricyanide and 2.5 ml of 1M hydrochloric acid showed 
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the maximum colour intensity. Hence these are selected as the optimized concentrations 
and volumes of ferric chloride, potassium ferricyanide and hydrochloric acid. 
Different aliquots of Tapentadol Hydrochloride were prepared in the 
concentration range of 1 to 10 µg/ ml. The absorbances of solutions were measured at 
737 nm. The calibration curve was plotted using concentration against absorbance. The 
preparation of calibration curve was repeated for six times. The optical characteristics 
like Correlation coefficient, Slope, Intercept, Molar absorptivity, Sandell’s sensitivity, 
LOD , LOQ and Residual Sum of Square were calculated. The correlation coefficient 
value for the calibration graph was found to be 0.9997. This indicates that the 
absorbance were linear with the concentration range of 1- 10 µg/ ml. The calibration 
curve of Tapentadol Hydrochloride is shown in figure 19. The optical characteristics are 
listed in table 26. 
To confirm the developed method, quantification of raw material was done and 
the amount was calculated. The percentage amount of Tapentadol Hydrochloride was 
found to be 100.16% ± 0.2605. The amount found by this method was close to 100%. 
Hence this method can be applied for the analysis of formulation. The results are shown 
in table 27.  
Tapol-100 tablets (MSN Laboratories Limited, Hyderabad), containing 100 mg 
of Tapentadol Hydrochloride) were selected for analysis. The nominal concentration of 
Tapentadol Hydrochloride from the linearity was prepared and the absorbance of the 
solution was measured at 737 nm. The amount of test solution was calculated by using 
slope and intercept valves. This procedure was repeated for six times to ensure the 
precision of the method. The percentage label claim in tablet formulation was found to 
be 100.13% ± 0.8343. The amount present in tablet formulation was good concord with 
the label claim and the Percentage Relative Standard Deviation (% RSD) value was 
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found to be 0.8332. The low % RSD value indicates that the method has good precision. 
The results of analysis are shown in table 28. 
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis was found to be 0.2572 and 0.5914, respectively. The reports of 
analysis are shown in tables 29 and 30, respectively. The results showed that the 
intermediate precision of the method was confirmed.  
The developed method was validated for Ruggedness. It refers to the analysis 
should be done in same laboratory which may include multiple analysts, multiple 
instruments and different sources of the reagents and so on. In the present work, it was 
confirmed by different analysts and different instrument. The percentage RSD value for 
analyst 1 and analyst 2 was found to be 0.2819 and 0.7941, respectively. The % RSD 
value for instrument 1 and instrument 2 were found to be 0.7349 and 0.3157, 
respectively. The low % RSD values indicate that the method was more rugged. Reports 
of analysis are shown in tables 31 and 32 for different analysts and different 
instruments, respectively. 
The accuracy of the method was confirmed by recovery studies. To the 
preanalyzed formulation a known quantity of Tapentadol Hydrochloride raw material 
solution was added at three different concentrations. The concentrations of standard 
were 80%, 100% and 120% of the sample concentration. The absorbance of the 
solutions was measured and the percentage recovery was calculated.  The percentage 
recovery was found to be in the range of 100.13% to 100.75% of Tapentadol 
Hydrochloride. The % RSD values were found to be less than 2. The low % RSD values 
indicated that there is no interference due to excipients used in formulation during the 
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analysis of Tapentadol Hydrochloride from tablets formulation. Hence the method was 
found to be accurate. The recovery data are shown in table 33. 
5.4 HPTLC METHOD 
The initial separation was made using various mobile phase using chloroform, 
methanol, formic acid, acetic acid, toluene, ethyl acetate, ethanol, ammonia and water 
in different combinations. The mobile phase tried were n-butanol: Methanol :Ammonia 
(5:4:1 % v/v/v), Ethanol: Ethyl Acetate: Water (6:3:1 % v/v/v), Ethanol: Hexane: Water 
(7:1:2 % v/v/v), Ethanol: Toluene: Water (7:1:2 % v/v/v), n-butanol: Methanol: 
Ammonia (5:4:1 % v/v/v), n-butanol: Methanol: Ammonia (3:6:1 % v/v/v),                  
n-butanol: Methanol: Ammonia (6:3:1 % v/v/v), n-butanol: Methanol: Ammonia   
(7:2:1 % v/v/v), Methanol: Ethyl acetate: Water (9:0.5:0.5 % v/v/v),                 
Methanol: Ethyl acetate: Water (8:1:1 % v/v/v), Methanol: Ethyl acetate: Water     
(7:2:1 % v/v/v), Methanol: Ethyl acetate: Water (6:3:1 % v/v/v) were tried. 
 In n-butanol: Methanol :Ammonia (5:4:1 % v/v/v) the drug was separated and 
the Rf value found to be 0.90. The Rf value of Tapentadol Hydrochloride was beyond 
the normal values (range from 0.2 to 0.8), (P.D Sethi et al). Hence the different ratios 
were tried with the same mobile phase. But there was no remarkable improvement. 
Hence the mobile phase was switched to Ethanol: Ethyl Acetate: Water (6:3:1 % v/v/v).  
The Rf value was found to be 0.42. In Methanol: Ethyl Acetate: Water (8:1:1 % v/v/v), 
the improved Rf value was 0.50. The different ratios of mobile phase were tried       
(Methanol: Ethyl acetate: Water (9:0.5:0.5 % v/v/v), Methanol: Ethyl acetate: Water 
(8:1:1 % v/v/v), Methanol: Ethyl acetate: Water (7:2:1 % v/v/v),                       
Methanol: Ethyl acetate: Water (6:3:1 % v/v/v)). Methanol: Ethyl acetate: Water in the 
ratio of 8:1:1 % v/v was selected for the method since, the drug was eluted with good 
resolution. 270 nm was selected as the detection wavelength for the analysis. The 
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spectral conformation of the standard Tapentadol Hydrochloride with sample solution 
Tapentadol Hydrochloride is given in figure 20. 
1 mg/ ml stock solution of Tapentadol Hydrochloride was prepared in methanol. 
From the stock solution concentration range of 100 to 600 ng/ µl of Tapentadol 
Hydrochloride chromatogram were developed in the Twin trough Chamber. The 
linearity chromatograms are shown in figure 21 to 26. The calibration graph was plotted 
with concentration versus peak area and the correlation coefficient was found to be 
0.9995 for Tapentadol Hydrochloride. The calibration graph for Tapentadol 
Hydrochloride was shown in figure 27. The optical characteristics such as the LOD, 
LOQ, Slope, Intercept, Regression equation and correlation coefficient are given in 
table 34. 
The tablet powder equivalent to 10 mg of Tapentadol Hydrochloride was taken 
and dissolved in 10 ml of methanol. The solution was sonicated for 15 minutes and 
made up to the volume with methanol. This solution was centrifuged at 2000 rpm for 15 
minutes and the supernatant liquid is filtered through a Whatmann filter paper no 41. 
This solution was diluted to get a final solution containing 100 ng/ µl of Tapentadol 
Hydrochloride theoretically. Six spots were made on the plates with 3 µl solution for 
each spot. The chromatogram was developed and the peak areas were noted. The 
percentage purity of Tapentadol Hydrochloride was found to be 99.97% ± 0.2196. The 
%RSD values for Tapentadol Hydrochloride 0.2197. The chromatograms are given in 
figures 28 – 33. The data is given in table 35.  
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The chromatograms are given in           
figures 34 – 39. The percentage RSD value for intraday and inter day analysis of 
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Tapentadol Hydrochloride was found to be 0.0551 and 0.0635, respectively. The reports 
of analysis are shown in tables 36 and 37, respectively. The results showed that the 
precision of the method was further confirmed.  
The accuracy of the method is confirmed by the recovery analysis. To the pre-
analyzed formulation, known quantities of the standard drugs were added at three 
different concentrations. The amount of Tapentadol Hydrochloride recovered was in the 
range of 99.96% to 100.36%. The %RSD values were found to be less than 2. The low 
%RSD values indicate that there is no interference of the excipients during the analysis. 
The peaks of the developed chromatograms are given in figures 40 to 42.The data of 
recovery analysis are given in table 38.  
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6. SUMMARY AND CONCLUSION 
Four simple, rapid, precise and accurate UV - Visible spectrophotometric 
methods and an isocratic HPTLC method were developed and validated for estimation 
of Tapentadol Hydrochloride in pure form and in tablet dosage form.  
The methods employed for the analysis of Tapentadol Hydrochloride were 
1) UV spectroscopic method 
2) Difference spectrophotometric method 
3) Visible spectrophotometric method 
a) Method - I (using MBTH reagent) 
b) Method - II (using potassium ferricyanide) 
4) HPTLC method  
6.1 UV SPECTROSCOPIC METHOD   
From the solubility data the solvent selected for solubility was found to be 
distilled water. The λmax of Tapentadol Hydrochloride in Distilled water was         
272.5 nm. 
Tapentadol Hydrochloride was linear with the concentration range of               
10 - 60 µg/ ml. The correlation coefficient value for the calibration graph was found to 
be 0.9999. The amount of Tapentadol Hydrochloride present in the prepared raw 
material solution was found to be 98.21 ± 0.6159. 
Tapol-100 tablets (MSN Laboratories Limited Hyderabad), containing 100 mg 
of Tapentadol Hydrochloride) were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 100.56 ± 0.3153 of Tapentadol 
Hydrochloride. The precision of the method was confirmed by the repeated analysis of 
formulation. The %RSD was found to be 0.3136. 
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Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Tapentadol 
Hydrochloride was found to be 0.2781 and 0.3495, respectively. The developed method 
was validated for ruggedness. The percentage RSD value by analyst 1 and analyst 2 
were found to be 0.3669 and 0.3980 respectively and by instrument 1 and instrument 2 
were found to be 0.3538 and 0.8992 respectively. The low % RSD values indicate that 
the developed method was more rugged. The accuracy of the method was confirmed by 
recovery studies. The percentage recovery was found to be in the range of 100.46% to 
100.63% of Tapentadol Hydrochloride.  
6.2 DIFEERENCE SPECTROSCOPIC METHOD 
 Difference spectroscopic method is based on measurement of absorbance 
difference (amplitude) of Tapentadol Hydrochloride at maxima 290 nm and minima 
269.5 nm in 0.1M sodium hydroxide and 0.1M hydrochloric acid solutions, 
respectively. The measured value is the mplitude of maxima and minima between two 
equimolar solutions of the analyte in difference chemical forms, which exhibits 
different spectral characteristics.   
Tapentadol Hydrochloride was linear with the concentration range of                 
3 - 18 µg/ ml. The correlation coefficient value for the calibration graph was found to be 
0.9999. The amount of Tapentadol Hydrochloride present in the prepared raw material 
solution was found to be 100.84 ± 0.2562. 
Tapol-100 tablets (MSN Laboratories Limited, Hyderabad) containing 100mg of 
Tapentadol Hydrochloride) were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 100.60 ± 0.5872 of Tapentadol 
Hydrochloride. The precision of the method was confirmed by the repeated analysis of 
formulation. The %RSD was found to be 0.5837. 
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Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Tapentadol 
Hydrochloride was found to be 0.3188 and 0.2667 respectively. The developed method 
was validated for ruggedness. The percentage RSD value by analyst 1 and analyst 2 
were found to be 0.2364 and 0.4066, respectively and by instrument 1 and instrument 2 
were found to be 0.7191 and 0.4620, respectively. The low % RSD values indicate that 
the developed method was more rugged. The accuracy of the method was confirmed by 
recovery studies. The percentage recovery was found to be in the range of 98.37% to 
99.04% of Tapentadol Hydrochloride.  
6.3 VISIBLE SPECTROPHOTOMETRIC METHOD 
6.3.1 Colorimetric Method – I 
Tapentadol Hydrochloride has a phenolic hydroxyl group, which on treatment 
with MBTH reagent (3-Methyl-2-benzothiazolinone hydrazone hydrochloride 
monohydrate) in the presence of oxidizing agent give stable orange red coloured 
chromogen.  
After optimizing the different concentrations and volumes of ceric ammonium 
sulphate and MBTH reagent, 10 µg/ ml Tapentadol Hydrochloride solution is prepared 
with 0.8ml of 0.7% MBTH reagent and 1ml of ceric ammonium sulphate are added 
with shaking, and made up to mark with distilled water. This solution was scanned and 
the recorded spectra showed that the λmax of Tapentadol Hydrochloride is at 514 nm.  
Tapentadol Hydrochloride obeyed Beer’s law in the concentration range of 2 to 
24 µg/ ml. The correlation coefficient value was found to be 0.9991. The amount of 
Tapentadol Hydrochloride present in the prepared raw material solution was found to 
be101.08% ± 0.7682. 
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Tapol-100 tablets (MSN Laboratories Limited, Hyderabad) containing 100mg of 
Tapentadol Hydrochloride) were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 100.05 ± 0.3318 of Tapentadol 
Hydrochloride. The precision of the method was confirmed by the reported analysis of 
formulation. The %RSD was found to be 0.3317. 
Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Tapentadol 
Hydrochloride was found to be 0.4819 and 0.2227 respectively. The developed method 
was validated for ruggedness. The percentage RSD value by analyst 1 and analyst 2 
were found to be 0.1247 and 0.3622 respectively and by instrument 1 and instrument 2 
were found to be 0.3564 and 0.7566, respectively. The low % RSD values indicate that 
the developed method was more rugged. The accuracy of the method was confirmed by 
recovery studies. The percentage recovery was found to be in the range of 101.23% to 
101.87% of Tapentadol Hydrochloride. 
6.3.2 Colorimetric Method - II 
 Tapentadol Hydrochloride has a phenolic hydroxyl group, which on 
treatment with ferric chloride and potassium ferricyanide in the presence of acidic 
medium (1M hydrochloric acid) give stable Prussian blue colored chromogen.  
After optimizing the different concentrations and volumes of ferric chloride, 
potassium ferricyanide and 1M hydrochloric acid, 10 µg/ ml Tapentadol Hydrochloride 
solution is prepared with 1.5ml of 0.5% of ferric chloride with 2min shaking, 3.2ml of 
0.1% potassium ferricyanide was added, stand for 2min and 2.5ml of 1N hydrochloric 
acid was added with shaking and kept aside for 2min, and made up to mark with 
distilled water. This solution was scanned and the recorded spectra showed that the 
λmax of Tapentadol Hydrochloride is at 737 nm.  
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Tapentadol Hydrochloride obeyed Beer’s law in the concentration range of 1 to 
10 µg/ ml. The optical characteristics like Correlation coefficient, Slope, Intercept, 
Molar absorptivity, Sandell’s sensitivity, LOD and LOQ were calculated. The 
correlation coefficient value was found to be 0.9997. The amount of Tapentadol 
Hydrochloride present in the prepared raw material solution was found to be      
100.16% ± 0.2605. 
Tapol-100 tablets (MSN Laboratories Limited, Hyderabad) containing 100 mg 
of Tapentadol Hydrochloride) were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 100.13 ± 0.8343 of Tapentadol 
Hydrochloride. The precision of the method was confirmed by the reported analysis of 
formulation. The %RSD was found to be 0.8332. 
Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Tapentadol 
Hydrochloride was found to be 0.2572 and 0.5914 respectively. The developed method 
was validated for ruggedness. The percentage RSD value by analyst 1 and analyst 2 
were found to be 0.2819 and 0.7941 respectively and by instrument 1 and instrument 2 
were found to be 0.7349 and 0.3157. The low % RSD values indicate that the developed 
method was more rugged. The accuracy of the method was confirmed by recovery 
studies. The percentage recovery was found to be in the range of 100.13% to 100.75% 
of Tapentadol Hydrochloride. 
6.4 HPTLC METHOD 
A simple and rapid HPTLC method was developed for Tapentadol 
Hydrochloride in bulk and in tablet dosage form. The mobile phase consisting of 
Methanol: Ethyl acetate: Water in the ratio of 8:1:1% v/v/v was selected for the 
analysis. From the spectral characteristics, 270 nm was selected as the detection 
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wavelength for the analysis. With the optimised conditions, the linearity range was 
fixed as 100 to 600 ng/ µl for Tapentadol Hydrochloride. The correlation coefficient for 
the Tapentadol Hydrochloride was found to be 0.9995. 
 Tapol-100 tablets (MSN Laboratories Limited, Hyderabad) containing 100 mg 
of Tapentadol Hydrochloride) were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 99.97 ± 0.2196 of Tapentadol 
Hydrochloride. The precision of the method was confirmed by the reported analysis of 
formulation. The %RSD was found to be 0.8332. 
Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Tapentadol 
Hydrochloride was found to be 0.0551 and 0.0635 respectively. 
The accuracy of the method was confirmed by recovery studies. The percentage 
recovery was found to be in the range of 99.96% to 100.36% of Tapentadol 
Hydrochloride. 
Four simple, precise, rapid and accurate UV-Visible spectrophotometric 
methods and HPTLC method were developed for the determination of Tapentadol 
Hydrochloride in bulk and in tablet formulation. 
When comparing all the five methods HPTLC method is very sensitive, because 
it is having low LOD and LOQ values. But remaining methods are very economic when 
compared to HPTLC, because the solvents and instruments used in HPTLC method are 
very costly. In UV-visible spectrophotometric methods, UV method with a simple 
solvent (Distilled water) is very less time consuming and economical method. But the 
linearity range is high because of low absorptivity. 
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In difference spectrophotometric method difficult to handle both the acidic and 
basic solutions containing drug at the time of preparation, dilutions, at the time of 
collecting the reading and it is time consuming method. 
Two colorimetric methods are forming well defined colours. But these methods 
also time consuming methods, because daily we have to prepare each and every reagent 
and they also ready to react so we need to prevent the contamination at the time of 
pipetting. At the same time cost of reagents also high. 
In HPTLC method preparation of mobile phase and the dilutions of the drug 
sample is very easy. When comparing with LOD and LOQ values of other methods 
HPTLC method have high sensitive in quantitative and qualitative analysis. But the cost 
of instrument and solvents used are very expensive. 
Although, the developed methods were validated according to ICH guide lines, 
and the results obtained in the validation (Accuracy, Precision, Repeatability, 
Intermediate Precision, Specificity, Detection Limit, Quantitation Limit, Linearity and 
Range) are within the limits according to ICH guide lines. Hence, it is suggested that 
the proposed UV-Visible spectrophotometric methods and HPTLC method can be 
effectively applied for the routine quality control analysis of Tapentadol 
Hydrochloride in bulk and in its tablet dosage form. 
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FIGURE – 1 
 
IR SPECTRUM OF  
TAPENTADOL HYDROCHLORIDE 
 
 
 
 
  
FIGURE - 2 
 
UV SPECTRUM OF TAPENTADOL HYDROCHLORIDE 
IN DISTILLED WATER (10 µg/ ml) 
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FIGURE - 3 
 
TAPENTADOL HYDROCHLORIDE
 AT 272.5 nm
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FIGURE - 4 
DIFFERENCE SPECTRA OF TAPENTADOL HYDROCHLORIDE 
(10 µg/ ml) 
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FIGURE - 5 
 
TAPENTADOL HYDROCHLORIDE
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FIGURE – 6 
 
VISIBLE SPECTRUM OF TAPENTADOL HYDROCHLORIDE  
BY COLORIMETRIC METHOD-I 
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FIGURE-7 
 
MOLAR SOLUTIONS
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FIGURE- 8 
WITH DIFFERENT VOLUMES 
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FIGURE - 9 
 
 WITH DIFFERENT 
CONCENTRATIONS 
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FIGURE - 10 
 
DIFFERENT VOLUMES 
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FIGURE – 11 
 
TAPENTADOL HYDRO CHLORIDE 
COLORIMETRIC METHOD – I 
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FIGURE – 12 
 
VISIBLE SPECTRUM OF TAPENTADOL HYDROCHLORIDE  
BY COLORIMETRIC METHOD-II 
 
 
 
 
 
 
 
 
 
OPTIMISATION OF FERRIC CHLORIDE
DIFFERENT 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 0.1 0.2
AB
SO
R
B
AN
CE
 
 
FIGURE - 13 
 
CONCENTRATIONS 
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FIGURE – 14 
 
DIFFERENT VOLUMES 
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FIGURE – 15 
 
CONCENTRATIONS 
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FIGURE – 16 
 
OPTIMISATION OF POTASSIUM FERRICYANIDE 
WITH DIFFERENT VOLUMES 
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FIGURE -17 
 
MOLAR SOLUTIONS 
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FIGURE – 18 
 
WITH DIFFERENT VOLUMES 
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FIGURE – 19 
 
TAPENTADOL HYDROCHLORIDE 
-II 
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FIGURE -20 
SPECTRAL CONFORMATION OF STANDARD TAPENTADOL 
HYDROCHLORIDE WITH FORMULATION BY HPTLC 
 
 
 
 
 
 
 
 
 
 
 
 
  
FIGURE - 21 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
(100 ng/ µl) 
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FIGURE - 22 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
(200 ng/ µl) 
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FIGURE - 23 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
(300 ng/ µl) 
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FIGURE - 24 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
 (400 ng/ µl) 
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FIGURE - 25 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
 (500 ng/ µl) 
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FIGURE - 26 
LINEARITY CHROMATOGRAM FOR TAPENTADOL 
HYDROCHLORIDE BY HPTLC 
 (600 ng/ µl) 
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FIGURE - 27 
FOR TAPENTADOL 
 BY HPTLC METHOD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
384.0333
557.9533
732.0066
899.6333
200 300 400 500
CONCENTRATION [ng/µl]
 
 
1074.3066
600 700
  
FIGURE – 28 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 1 
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FIGURE – 29 
 
      CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 2 
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FIGURE – 30 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 3 
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FIGURE - 31 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 4 
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FIGURE – 32 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 5 
 
 
 
 
 
 
Peak Start 
Rf 
Start 
Height 
Max 
Rf 
Max 
Height 
Max% End 
Rf 
End  
Height 
Area Area 
% 
1 0.46 2.2 0.49 38.1 100% 0.52 1.9 549.3 100% 
 
 
 
 
 
 
  
 
FIGURE – 33 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
REPEATABILITY 6 
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FIGURE - 34 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTRA DAY 1 
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FIGURE - 35 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTRA DAY 2 
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FIGURE - 36 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTRA DAY 3 
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FIGURE - 37 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTER DAY 1 
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FIGURE – 38 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTER DAY 2 
 
 
 
 
 
 
Peak Start 
Rf 
Start 
Height 
Max 
Rf 
Max 
Height 
Max% End 
Rf 
End  
Height 
Area Area 
% 
1 0.45 1.9 0.50 37.4 100% 0.52 2.1 551.4 100% 
 
 
 
 
 
 
 
  
FIGURE – 39 
 
CHROMATOGRAM FOR FORMULATION ANALYSIS BY HPTLC 
INTER DAY 3 
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FIGURE – 40 
 
CHROMATOGRAM FOR RECOVERY ANALYSIS BY HPTLC 
 (80%) 
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FIGURE - 41 
CHROMATOGRAM FOR RECOVERY ANALYSIS BY HPTLC 
 (100%) 
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FIGURE - 42 
CHROMATOGRAM FOR RECOVERY ANALYSIS BY HPTLC 
 (120%) 
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TABLE – 1 
 
SOLUBILITY PROFILE OF TAPENTADOL HYDROCHLORIDE IN POLAR 
AND NON-POLAR SOLVENTS 
S. No SOLVENTS EXTENT OF SOLUBILITY CATEGORY 
1. Distilled water 10mg in 10 µl Very soluble 
2. Methanol 10 mg in 20 µl Freely soluble 
3. Ethanol 10 mg in 40  µl Freely  soluble 
4. Acetonitrile 10 mg in 2.5 ml Slightly soluble 
5. Di-methylFormamide 10 mg in 40.0  µl Freely soluble 
6. Acetone 10 mg in more than 10.0ml Practically insoluble 
7. acetic acid 10 mg in 20.0 µl Freely soluble 
8. Ethyl acetate 10mg in 1.5ml Slightly soluble 
9. Chloroform 10 mg in more than 10.0 ml Practically insoluble 
10. Dichloromethane 10 mg in 6.0ml Slightly soluble 
11. n- Butanol 10 mg in 300.0 µl Soluble 
12. Pyridine 10 mg in 30.0  µl Freely soluble 
13. Benzene 10 mg in more than 10.0ml Practically insoluble 
14. Iso propyl alcohol 10 mg in 500.0 µl Sparingly soluble 
15. Toluene 10 mg in 7.0ml Slightly soluble 
16. Diethyl ether 10 mg in more than 10.0ml Practically insoluble 
17. 0.1N Hydrochloric Acid 10 mg in 10.0 µl Very soluble 
18. 0.1N Sodium Hydroxide 10 mg in 0.8 ml Sparingly soluble 
19. pH-3.0(acid phthalate buffer) 10mg in 10.0 µl Very soluble 
20. pH-5.0(neutralized phthalate buffer) 10mg in 10.0 µl Very soluble 
21. pH-7.0(phosphate buffer) 10mg in 10.0 µl Very soluble 
22. pH-9 (alkaline borate buffer) 10mg in 10.0 µl Very soluble 
  
TABLE – 2 
 
OPTICAL CHARACTERISTICS OF TAPENTADOL 
HYDROCHLORIDE BY UV METHOD 
 
               *Mean of six observations 
 
 
PARAMETERS VALUES* 
λmax (nm) 272.5 
Beer’s law limit (µg/ ml) 10 - 60 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U) 0.014411 
Molar absorptivity 
(L mol–1 cm–1) 2.885×10
3 
Correlation coefficient (r) 0.9999 
Regression equation 
(y=mx+c) Y = 0.0069x + 0.0019 
Slope(m) 0.0069 
Intercept(c) 0.0019 
LOD (µg/ ml) 0.4255 
LOQ (µg/ ml) 1.2893 
Standard error 
 
0.0002 
Residual sum of squares 0.000020 
  
 
TABLE - 3 
 
QUANTIFICATION OF RAW MATERIAL BY 
UV METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
 
 
Drug Sample 
No. 
Amount 
found 
(µg/ ml)* 
Percentage 
Obtained* 
(%) 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
19.6014 
 
19.5174 
 
19.8752 
 
19.6446 
 
19.5773 
 
19.6350 
 
98.01 
 
97.59 
 
99.38 
 
98.22 
 
97.89 
 
98.18 
 
 
 
 
 
98.21 
 
 
 
 
 
 
 
 
 
0.6159 
 
 
 
 
 
0.6271 
 
 
 
 
 
0.0171 
 
 
 
 
97.56 
to 
98.86 
  
 
TABLE - 4 
 
QUANTIFICATION OF FORMULATION TAPOL-100 BY  
UV METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
Drug Sample 
No. 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
%(w/v) 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
100.0mg 
 
100.0mg 
 
100.0mg 
 
100.0mg 
 
100.0mg 
 
100.0mg 
 
100.52 
 
100.14 
 
100.24 
 
100.92 
 
100.83 
 
100.68 
 
 
100.52 
 
100.14 
 
100.24 
 
100.92 
 
100.83 
 
100.68 
 
 
 
 
 
100.56 
 
 
 
 
 
 
 
 
 
0.3153 
 
 
 
 
 
0.3136 
 
 
 
 
 
0.0088 
 
 
 
 
100.23 
to 
100.89 
  
 
TABLE - 5 
 
INTRADAY ANALYSIS OF FORMULATION TAPOL-100 
BY UV METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
 
 
100 
 
 
100 
 
 
100 
 
 
 
100.05 
 
 
100.09 
 
 
99.59 
 
100.05 
 
 
100.09 
 
 
99.59 
 
 
 
 
99.91 
 
 
 
 
0.2779 
 
 
 
 
0.2781 
 
 
 
 
 
 
0.0309 
 
 
 
99.22 
to 
100.60 
  
 
TABLE - 6 
 
INTERDAY ANALYSIS OF FORMULATION TAPOL-100 
BY UV METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
 
 
100 
 
 
100 
 
 
100 
 
 
100.63 
 
 
99.93 
 
 
100.25 
 
100.63 
 
 
99.93 
 
 
100.25 
 
 
 
 
100.27 
 
 
 
 
0.3504 
 
 
 
 
0.3495 
 
 
 
 
 
 
0.0389 
 
 
 
99.40 
to 
101.14 
  
 
TABLE – 7 
 
RUGGEDNESS STUDY BY UV METHOD 
(DIFFERENT ANALYSTS) 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Mean of six observations 
Drug Condition Sample 
No 
Labeled 
Amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
TAP Analyst 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.38 
100.46 
99.49 
100.27 
100.34 
99.95 
100.38 
100.46 
99.49 
100.27 
100.34 
99.95 
 
 
 
100.15 
 
 
 
0.3674 
 
 
 
0.3669 
 
 
 
0.0102 
 
 
99.76 
to 
100.54 
TAP Analyst 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.92 
99.86 
100.93 
100.54 
100.52 
100.33 
100.92 
99.86 
100.93 
100.54 
100.52 
100.33 
 
 
 
100.52 
 
 
 
0.4000 
 
 
 
0.398 
 
 
 
0.0111 
 
 
100.10 
to 
100.94 
  
 
TABLE – 8 
 
RUGGEDNESS STUDY BY UV METHOD 
(DIFFERENT INSTRUMENTS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
 
Drug Condition Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
TAP 
 
 
Instrument 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.40 
100.25 
100.05 
100.09 
100.63 
99.59 
100.40 
100.25 
100.05 
100.09 
100.63 
99.59 
 
 
 
100.17 
 
 
 
0.3544 
 
 
 
0.3538 
 
 
 
0.0980 
 
99.80 
to 
100.54 
 
 
 
TAP 
 
 
 
Instrument 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.63 
100.99 
99.39 
98.42 
100.01 
99.82 
100.63 
100.99 
99.39 
98.42 
100.01 
99.82 
 
 
 
100.04 
 
 
 
0.8996 
 
 
 
0.8992 
 
 
 
0.0250 
 
98.10 
to 
100.98 
  
 
TABLE – 9 
 
RECOVERY ANALYSIS OF FORMULATION TAPOL -100 
BY UV METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 *Mean of three observations 
 
 
Drug Sample 
No 
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount  
found* 
(µg/ml) 
Amount 
recovered 
(µg/ml) 
% Recovered SD % 
RSD 
SE CI 
 
TAP 
1 
2 
3 
20.1803 
20.1803 
20.1803 
15.5207 
15.5159 
15.5495 
35.6907 
35.9453 
35.7819 
15.5104 
15.7650 
15.6016 
99.93 
101.61 
100.34 
 
0.8759 
 
0.8705 
 
 
 
0.0973 
98.45 
to 
102.81 
Mean 100.63 
 
TAP 
1 
2 
3 
20.1803 
20.1803 
20.1803 
19.5005 
19.4782 
19.4169 
39.6248 
39.9562 
39.6609 
19.4445 
19.7759 
19.4806 
99.71 
101.53 
100.33 
 
0.9253 
 
0.9205 
 
0.1028 
98.22 
to 
102.82 
Mean 100.52 
 
TAP 
1 
2 
3 
20.1803 
20.1803 
20.1803 
23.5857 
23.5617 
23.7203 
44.0297 
43.7822 
43.9239 
23.8494 
23.6019 
23.7436 
101.11 
100.17 
100.10 
 
0.5640 
 
0.5614 
 
0.0627 
99.05 
to 
101.86 
Mean 100.46 
  
TABLE – 10 
 
OPTICAL CHARACTERISTICS OF TAPENTADOL 
HYDROCHLORIDE BY DIFFERENCE 
SPECTROPHOTOMETRIC METHOD 
 
         *Mean of six observations 
 
 
PARAMETERS VALUES* 
Wave length maxima 290 nm 
Wave length minima 269.5 nm  
Beer’s law limit (µg/ ml) 3 - 18 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U) 0.2452 
Molar absorptivity 
(L mol–1 cm–1) 1.6858 × 10
3
 
Correlation coefficient (r) 0.9999 
Regression equation 
(y=mx+c) Y = 0.0136x + (-0.0001) 
Slope(m) 0.0136 
Intercept(c) -0.0001 
LOD (µg/ ml) 0.6689 
LOQ (µg/ ml) 2.0270 
Standard error 
 
0.0002 
Residual sum of squares 0.0000045 
  
 
TABLE – 11 
 
QUANTIFICATION OF RAW MATERIAL BY DIFFERENCE  
SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     *Mean of six observations 
 
 
 
 
Drug Sample 
No. 
Amount 
found 
(µg/ml)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
12.0746 
 
12.1064 
 
12.0966 
 
12.0819 
 
12.0893 
 
12.1592 
 
 
100.62 
 
100.89 
 
100.80 
 
100.68 
 
100.74 
 
101.33 
 
 
 
 
 
100.84 
 
 
 
 
 
 
 
 
 
0.2562 
 
 
 
 
 
0.2540 
 
 
 
 
 
0.0071 
 
 
100.57 
to 
101.11 
  
 
TABLE – 12 
 
QUANTIFICATION OF FORMULATION TAPOL-100 
BY DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
100 
 
100 
 
100 
 
100 
 
100 
 
100 
 
101.4080 
 
99.7941 
 
101.1525 
 
100.3758 
 
100.5083 
 
100.3700 
 
101.41 
 
99.79 
 
101.15 
 
100.38 
 
100.51 
 
100.37 
 
 
 
 
 
100.60 
 
 
 
 
 
0.5872 
 
 
 
 
 
0.5837 
 
 
 
 
 
0.0163 
 
 
 
 
99.98 
to 
101.21 
 
  
 
TABLE – 13 
 
INTRADAY ANALYSIS OF FORMULATION TAPOL-100 
BY DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     *Mean of six observations 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
 
 
100 
 
 
100 
 
 
100 
 
 
99.8550 
 
 
99.8350 
 
 
99.3033 
 
99.86 
 
 
99.84 
 
 
99.30 
 
 
 
 
99.67 
 
 
 
 
0.3177 
 
 
 
 
0.3188 
 
 
 
 
 
 
0.0353 
 
 
98.88 
to 
100.46 
  
 
TABLE –14 
 
INTERDAY ANALYSIS OF FORMULATION TAPOL-100 
BY DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
       *Mean of six observations 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
 
 
100 
 
 
100 
 
 
100 
 
 
100.0967 
 
 
99.8750 
 
 
99.5683 
 
100.10 
 
 
99.88 
 
 
99.57 
 
 
 
 
99.85 
 
 
 
 
0.2663 
 
 
 
 
0.2667 
 
 
 
 
 
 
0.0296 
 
 
99.19 
to 
100.51 
  
 
TABLE –15 
 
RUGGEDNESS STUDY BY  
DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
        *Mean of six observations 
 
 
Drug Condition Sample 
No 
Labeled 
Amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
TAP Analyst 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
99.8508 
99.8958 
100.1917 
99.9875 
99.5683 
99.5958 
99.85 
99.90 
100.19 
99.99 
99.57 
99.60 
 
 
 
99.85 
 
 
 
0.2361 
 
 
 
0.2364 
 
 
 
0.0066 
 
99.60 
to 
100.10 
TAP Analyst 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.5296 
100.2951 
100.0993 
99.4164 
100.3769 
99.8456 
100.53 
100.30 
100.10 
99.42 
100.38 
99.85 
 
 
 
100.10 
 
 
 
0.4070 
 
 
 
0.4066 
 
 
 
0.0113 
 
99.67 
to 
100.53 
  
 
TABLE – 16 
 
RUGGEDNESS STUDY BY DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
 
 
Drug Condition Sample No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
TAP 
 
 
Instrument 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
101.4083 
101.1525 
100.5083 
99.8550 
99.3033 
100.0967 
101.41 
101.15 
100.51 
99.86 
99.30 
100.10 
 
 
 
100.39 
 
 
 
0.7219 
 
 
 
0.7191 
 
 
 
0.0201 
 
99.63 
to 
101.15 
 
 
 
TAP 
 
 
 
Instrument 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.4067 
100.0249 
100.0822 
100.1314 
101.2742 
100.3680 
100.41 
100.03 
100.08 
100.13 
101.27 
100.37 
 
 
 
100.38 
 
 
 
0.4637 
 
 
 
0.4620 
 
 
 
0.0129 
 
99.89 
to 
100.87 
  
 
TABLE – 17 
 
RECOVERY ANALYSIS OF FORMULATION TAPOL-100 
BY DIFFERENCE SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Mean of three observations 
 
Drug Sample 
No 
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount  
found* 
(µg/ml) 
Amount 
recovered 
(µg/ml) 
% Recovered SD % 
RSD 
SE CI 
 
TAP 
1 
2 
3 
6.0506 
6.0506 
6.0506 
4.4042 
4.4153 
4.3859 
 
10.3879 
10.4137 
10.3765 
4.3373 
4.3631 
4.3259 
98.48 
98.82 
99.24 
 
0.3807 
 
0.3851 
 
 
 
0.0423 
97.90 
to 
99.80 
Mean 98.85 
 
TAP 
1 
2 
3 
6.0506 
6.0506 
6.0506 
5.8800 
5.9724 
5.8901 
 
11.8700 
11.9740 
11.8797 
5.8194 
5.9234 
5.8291 
98.97 
99.18 
98.96 
 
0.1242 
 
0.1254 
 
0.0138 
98.73 
to 
99.35 
Mean 99.04 
 
TAP 
1 
2 
3 
6.0506 
6.0506 
6.0506 
7.3517 
7.3237 
7.2267 
13.2640 
13.2455 
13.1867 
7.2134 
7.1949 
7.1361 
98.12 
98.24 
98.75 
 
0.3345 
 
0.3401 
 
0.0372 
97.54 
to 
99.20 
Mean 98.37 
  
TABLE – 18 
 
OPTICAL CHARACTERISTICS OF TAPENTADOL 
HYDROCHLORIDE BY COLORIMETRIC METHOD-I 
 
 
         *Mean of six observations 
 
 
 
PARAMETERS VALUES* 
λmax (nm) 514 
Beer’s law limit (µg/ ml) 2-24 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U) 0.02044 
Molar absorptivity 1.1366 ×104 
Correlation coefficient (r) 0.9991 
Regression equation 
(y = mx + c) Y = 0.0490x + 0.0237 
Slope (m) 0.0490 
Intercept (c) 0.0237 
LOD (µg/ ml) 1.0473 
LOQ (µg/ ml) 3.1736 
Standard error 
 
0.0008 
Residual sum of squares 0.001028 
  
 
TABLE –19 
 
QUANTIFICATION OF RAW MATERIAL  
BY COLORIMETRIC METHOD-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    *Mean of six observations 
 
 
 
 
 
Drug Sample 
No. 
Amount 
found 
(µg/ml)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
10.0348 
 
10.0660 
 
10.1216 
 
10.2138 
 
10.1780 
 
10.0328 
 
100.35 
 
100.66 
 
101.22 
 
102.14 
 
101.78 
 
100.33 
 
 
 
 
 
101.08 
 
 
 
 
 
 
 
 
0.7682 
 
 
 
 
 
 
 
0.7600 
 
 
 
 
 
 
0.0213 
 
 
 
100.27 
to 
101.89 
  
 
TABLE – 20 
 
QUANTIFICATION OF FORMULATION TAPOL-100 BY 
COLORIMETRIC METHOD-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
100 
 
100 
 
100 
 
100 
 
100 
 
100 
 
99.5420 
 
100.0490 
 
99.7708 
 
100.3673 
 
100.3400 
 
100.2100 
 
99.54 
 
100.05 
 
99.77 
 
100.37 
 
100.34 
 
100.21 
 
 
 
 
 
100.05 
 
 
 
 
 
0.3318 
 
 
 
 
 
0.3317 
 
 
 
 
 
0.0092 
 
 
 
99.70 
to 
100.40 
  
 
TABLE – 21 
 
INTRADAY ANALYSIS OF FORMULATION TAPOL-100 
BY COLORIMETRIC METHOD-I 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         *Mean of three observations 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)
* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
99.6980 
 
 
100.2160 
 
 
99.2619 
 
99.70 
 
 
100.22 
 
 
99.26 
 
 
 
 
99.73 
 
 
 
 
0.4806 
 
 
 
 
0.4819 
 
 
 
 
0.0534 
 
 
99.54 
To 
100.92 
  
 
TABLE – 22 
 
INTERDAY ANALYSIS OF FORMULATION TAPOL-100 
BY COLORIMETRIC METHOD-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of three observations 
 
 
 
 
 
 
 
Drug Sample  
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) SD % RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
100.0250 
 
 
99.7473 
 
 
100.1850 
 
100.03 
 
 
99.75 
 
 
100.19 
 
 
 
 
99.99 
 
 
 
 
0.2227 
 
 
 
 
0.2227 
 
 
 
 
 
 
0.0247 
 
 
99.44 
to 
100.54 
  
 
TABLE – 23 
 
RUGGEDNESS STUDY BY COLORIMETRIC METHOD-I 
(DIFFERENT ANALYSTS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
Drug Condition Sample 
No 
Labeled 
Amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
TAP Analyst 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.0490 
100.3673 
100.2100 
100.2160 
100.0250 
100.1850 
100.05 
100.37 
100.21 
100.22 
100.03 
100.19 
 
 
 
100.18 
 
 
 
0.1250 
 
 
 
0.1247 
 
 
 
0.0035 
 
 
100.05 
to 
100.31 
TAP Analyst 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.0968 
100.6480 
100.4330 
101.0460 
101.0360 
100.6100 
100.10 
100.65 
100.43 
101.05 
101.04 
100.61 
 
 
 
100.65 
 
 
 
0.3646 
 
 
 
0.3622 
 
 
 
0.0101 
 
 
100.27 
to 
101.03 
  
 
TABLE – 24 
 
RUGGEDNESS STUDY BY COLORIMETRIC METHOD-I 
(DIFFERENT INSTRUMENTS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
 
Drug Condition Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
TAP 
 
 
Instrument 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
99.5420 
99.7701 
100.3400 
99.6980 
99.2619 
99.7400 
99.54 
99.77 
100.34 
99.70 
99.26 
99.74 
 
 
 
99.73 
 
 
 
0.3554 
 
 
 
0.3564 
 
 
 
0.0099 
 
 
99.36 
to 
100.10 
 
 
TAP 
 
 
Instrument 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.3580 
101.5530 
102.3400 
102.1480 
101.0530 
100.8760 
100.36 
101.55 
102.34 
102.15 
101.05 
100.88 
 
 
101.39 
 
 
0.7671 
 
 
0.7566 
 
 
0.0213 
 
100.59 
to 
102.20 
  
 
TABLE – 25 
 
RECOVERY ANALYSIS OF FORMULATION TAPOL-100 
BY COLORIMETRIC METHOD-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 *Mean of three observations 
 
Drug Sample 
No 
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount  
found* 
(µg/ml) 
Amount 
recovered 
(µg/ml) 
% Recovered SD % 
RSD 
SE CI 
TAP 
1 
2 
3 
10.0038 
10.0038 
10.0038 
7.9759 
7.9449 
8.0419 
 
18.1384 
18.1426 
18.1419 
8.1346 
8.1388 
8.1381 
101.99 
102.44 
101.19 
 
 
0.6331 
 
 
0.6215 
 
 
0.0703 
100.30 
to 
103.44 
Mean 101.87 
TAP 
1 
2 
3 
10.0038 
10.0038 
10.0038 
9.9722 
10.0426 
10.1632 
20.1483 
20.2334 
20.2187 
10.1445 
10.2296 
10.2149 
101.73 
101.86 
100.51 
 
 
0.7447 
 
 
0.7347 
 
 
0.0828 
99.52 
to 
103.22 
Mean 101.37 
TAP 
1 
2 
3 
10.0038 
10.0038 
10.0038 
12.1469 
12.1261 
12.1302 
22.3246 
22.2682 
22.2712 
12.3208 
12.2644 
12.2674 
101.43 
101.14 
101.13 
 
 
0.1700 
 
 
0.1679 
 
 
0.0188 
100.81 
to 
101.65 
Mean 101.23 
  
 
TABLE – 26 
 
OPTICAL CHARACTERISTICS OF TAPENTADOL.HCL 
BY COLORIMETRIC METHOD-II 
 
 
         *Mean of six observations 
 
PARAMETERS VALUES* 
λmax (nm) 737 
Beer’s law limit (µg/ ml) 1-10 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U) 0.0063 
Molar absorptivity 4.1435 × 104 
Correlation coefficient (r) 0.9997 
Regression equation 
(y = mx + c) Y = 0.1594x + 0.0133 
Slope (m) 0.1594 
Intercept (c) 0.0133 
LOD (µg/ ml) 0.1605 
LOQ (µg/ ml) 0.4865 
Standard error 
 
0.0009 
Residual sum of squares 0.000711 
  
 
TABLE –27 
 
QUANTIFICATION OF RAW MATERIAL  
BY COLORIMETRIC METHOD-II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
 
 
 
Drug Sample 
No. 
Amount 
found 
(µg/ml)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
4.0084 
 
4.0128 
 
4.0168 
 
4.0107 
 
3.9955 
 
3.9904 
 
100.21 
 
100.32 
 
100.42 
 
100.27 
 
99.89 
 
99.76 
 
 
 
 
 
 
100.16 
 
 
 
 
 
 
 
 
0.2605 
 
 
 
 
 
 
 
0.2601 
 
 
 
 
 
 
0.0072 
 
 
 
99.89 
to 
100.43 
  
 
TABLE – 28 
 
QUANTIFICATION OF FORMULATION TAPOL-100 BY 
COLORIMETRIC METHOD-II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % RSD SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
100 
 
100 
 
100 
 
100 
 
100 
 
100 
 
98.5923 
 
99.9150 
 
100.1790 
 
100.5816 
 
100.4980 
 
100.9789 
 
98.59 
 
99.92 
 
100.18 
 
100.58 
 
100.5 
 
100.98 
 
 
 
 
 
 
100.13 
 
 
 
 
 
0.8343 
 
 
 
 
 
0.8332 
 
 
 
 
 
0.0232 
 
 
 
99.25 
to 
101.01 
  
 
TABLE – 29 
 
INTRADAY ANALYSIS OF FORMULATION TAPOL-100 
BY COLORIMETRIC METHOD-II 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        *Mean of six observations 
 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % RSD SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
100.0614 
 
 
99.6222 
 
 
100.066 
 
100.06 
 
 
99.62 
 
 
100.07 
 
 
 
 
99.92 
 
 
 
 
0.2570 
 
 
 
 
0.2572 
 
 
 
 
0.0286 
 
 
 
99.28 
to 
100.56 
  
 
TABLE – 30 
 
INTERDAY ANALYSIS OF FORMULATION TAPOL-100 
BY COLORIMETRIC METHOD-II 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
 
 
 
 
 
Drug Sample No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % RSD SE CI 
 
 
 
 
TAP 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
99.6693 
 
 
100.6496 
 
 
100.7437 
 
99.67 
 
 
100.65 
 
 
100.74 
 
 
 
 
100.35 
 
 
 
 
0.5935 
 
 
 
 
0.5919 
 
 
 
 
 
 
0.0659 
 
 
 
98.88 
to 
101.82 
  
 
TABLE – 31 
 
RUGGEDNESS STUDY BY COLORIMETRIC METHOD-II 
(DIFFERENT ANALYSTS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    *Mean of six observations 
 
 
Drug Condition Sample 
No 
Labeled 
Amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
TAP Analyst 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
99.9150 
100.1790 
100.4980 
100.0614 
100.0666 
100.6496 
99.92 
100.18 
100.50 
100.07 
100.07 
100.65 
 
 
 
100.23 
 
 
 
0.2825 
 
 
 
0.2819 
 
 
 
0.0078 
 
 
99.93 
to 
100.53 
TAP Analyst 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
100.0144 
100.3777 
99.1962 
98.3623 
100.1215 
100.2967 
100.01 
100.38 
99.20 
98.36 
100.12 
100.30 
 
 
 
99.73 
 
 
 
0.7919 
 
 
 
0.7941 
 
 
 
0.0220 
 
 
98.90 
to 
100.56 
  
 
TABLE – 32 
 
RUGGEDNESS STUDY BY COLORIMETRIC METHOD –II 
(DIFFERENT INSTRUMENTS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of six observations 
 
 
 
Drug Condition Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Mean 
(%) 
SD % 
RSD 
SE CI 
 
 
 
TAP 
 
 
 
Instrument 1 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
98.5923 
100.1790 
100.4980 
100.0614 
100.0666 
100.6496 
98.59 
100.18 
100.50 
100.06 
100.07 
100.65 
 
 
 
100.01 
 
 
 
0.7350 
 
 
 
0.7349 
 
 
 
0.0204 
 
 
99.24 
to 
100.78 
 
 
 
TAP 
 
 
 
Instrument 2 
1 
2 
3 
4 
5 
6 
100 
100 
100 
100 
100 
100 
101.5645 
100.8979 
100.9685 
100.6260 
101.0600 
100.8169 
101.57 
100.90 
100.97 
100.63 
101.06 
100.82 
 
 
 
100.99 
 
 
 
0.3188 
 
 
 
0.3157 
 
 
 
0.0089 
 
 
100.66 
to 
101.32 
  
 
TABLE – 33 
 
RECOVERY ANALYSIS OF FORMULATION - TAPOL-100 
BY COLORIMETRIC METHOD-II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     *Mean of three observations 
 
 
Drug Sample 
No 
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount  
found* 
(µg/ml) 
Amount 
recovered 
(µg/ml) 
% Recovered SD % 
RSD 
SE CI 
TAP 
1 
2 
3 
4.0050 
4.0050 
4.0050 
3.2006 
3.2232 
3.2119 
7.2550 
7.2408 
7.2324 
3.2500 
3.2358 
3.2274 
101.37 
100.39 
100.48 
 
 
0.5436 
 
 
0.5396 
 
 
0.0604 
99.41 
to 
102.10 
Mean 100.75 
TAP 
1 
2 
3 
4.0050 
4.0050 
4.0050 
4.0183 
4.0812 
4.0066 
8.0766 
8.0505 
8.0241 
4.0716 
4.0455 
4.0191 
101.33 
99.13 
100.31 
 
 
1.1010 
 
 
1.0982 
 
 
0.1222 
97.53 
to 
103.00 
Mean 100.26 
TAP 
1 
2 
3 
4.0050 
4.0050 
4.0050 
4.7971 
4.8366 
4.7530 
8.8573 
8.8319 
8.7315 
4.8523 
4.8269 
4.7265 
101.15 
99.80 
99.44 
 
 
0.9015 
 
 
0.9003 
 
 
0.1002 
97.89 
to 
102.37 
Mean 100.13 
  
TABLE – 34 
 
   OPTICAL CHARACTERISTICS OF TAPENTADOL 
HYDROCHLORIDE BY HPTLC METHOD 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      *Mean of six observations 
 
 
 
 
 
 
 
 
PARAMETERS VALUES* 
Detection wavelength (nm) 270 
Beer’s law limit (ng/µl) 100 - 600 
Correlation coefficient (r) 0.9996 
Regression equation 
(y = mx + c) Y = 1.7701x + 19.6638 
Slope (m) 1.7701 
Intercept (c) 19.6638 
LOD (ng/ µl) 4.3933 
LOQ (ng/ µl) 13.3129 
Standard error 
 
0.6917 
  
 
TABLE – 35 
 
QUANTIFICATION OF FORMULATION TAPOL-100 BY 
HPTLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     *Mean of six observations 
 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
100 
 
100 
 
100 
 
100 
 
100 
 
100 
 
99.9446 
 
100.3275 
 
100.0859 
 
99.8097 
 
99.7061 
 
99.9101 
 
99.95 
 
100.33 
 
100.09 
 
99.81 
 
99.71 
 
99.91 
 
 
 
 
 
99.97 
 
 
 
 
 
0.2196 
 
 
 
 
 
0.2197 
 
 
 
 
 
0.0061 
 
 
 
 
99.74 
to 
100.20 
  
 
TABLE – 36 
 
INTRADAY ANALYSIS OF FORMULATION TAPOL-100 
BY HPTLC METHOD 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     *Mean of six observations 
 
 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
 
TAP 
 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
99.9948 
 
 
100.0105 
 
 
100.1016 
 
100.00 
 
 
100.01 
 
 
100.10 
 
 
 
 
100.04 
 
 
 
 
0.0551 
 
 
 
 
0.0551 
 
 
 
 
0.0061 
 
 
 
99.90 
To 
100.18 
  
 
TABLE – 37 
 
INTERDAY ANALYSIS OF FORMULATION TAPOL-100 
BY HPTLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
    *Mean of six observations 
 
 
 
 
 
 
 
Drug Sample 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* Mean (%) 
SD % 
RSD 
SE CI 
 
 
 
 
TAP 
 
 
 
 
 
1 
 
 
2 
 
 
3 
 
100 
 
 
100 
 
 
100 
 
100.1016 
 
 
99.9854 
 
 
99.9917 
 
100.10 
 
 
99.99 
 
 
99.99 
 
 
 
 
100.03 
 
 
 
 
0.0635 
 
 
 
 
0.0635 
 
 
 
 
 
 
0.0071 
 
 
 
99.87 
To 
100.19 
  
 
TABLE –38 
 
RECOVERY ANALYSIS OF FORMULATION TAPOL-100 
BY HPTLC METHOD 
 
 
 
        *Mean of three observations 
 
 
 
 
Drug Sample 
No 
Amount 
present 
(ng/µl) 
Amount 
added 
(ng/ µl ) 
Amount  
found* 
(ng/ µl ) 
Amount 
recovered 
(ng/ µl ) 
% Recovered SD % 
RSD 
SE CI 
TAP 
1 
2 
3 
299.8920 
299.8920 
299.8920 
240.0 
240.0 
240.0 
541.5152 
540.2158 
539.0294 
 
241.6232 
240.3238 
239.1374 
100.68 
100.14 
99.64 
 
 
0.5201 
 
 
0.5193 
 
 
0.0578 
98.86 
to 
101.44 
Mean 100.15 
TAP 
1 
2 
3 
299.8920 
299.8920 
299.8920 
300.0 
300.0 
300.0 
 
602.0202 
601.0033 
599.9299 
302.1282 
301.1113 
300.0379 
100.71 
100.37 
100.01 
 
 
0.3500 
 
 
0.3488 
 
 
0.0389 
99.49 
to 
101.23 
Mean 100.36 
TAP 
1 
2 
3 
299.8920 
299.8920 
299.8920 
360.0 
360.0 
360.0 
658.8532 
660.6610 
659.7006 
358.9612 
360.7690 
359.8086 
99.71 
100.21 
99.95 
 
 
0.2501 
 
 
0.2502 
 
 
0.0278 
99.34 
to 
100.58 
Mean 99.96 
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